2011 Tables: Illicit Drug Use - 1.47 to 1.92 (PE), SAMHSA, CBHSQ

120405

Table 1.47A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	16,367	15,540	566	541	293	257
GENDER
Male	11,206	10,507	445	448	250	223
Female	5,161	5,033	122	93	43	35
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15,011	14,186	493	518	239	251
White	13,601	13,030	455	412	230	203
Black or African American	687	527	25	28	3	27
American Indian or Alaska Native	173^a	74	1	*	*	*
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	259	172	1	31	*	10
Two or More Races	271	330	12	20	5	7
Hispanic or Latino	1,355	1,354	73	23	54^a	6
EDUCATION
< High School	1,891	1,649	44	79	10	69
High School Graduate	3,662	3,635	59	94	34	41
Some College	4,515	4,272	279	131	132	74
College Graduate	6,300	5,985	183	237	117	74
CURRENT EMPLOYMENT
Full-Time	10,700	9,831	388	285	222	142
Part-Time	2,123	1,987	80^a	6	38	*
Unemployed	933	1,060	29	82	29	20
Other¹	2,612	2,662	68	167	4^a	95

120405

Table 1.47B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	8.4	7.8	0.3	0.3	0.2	0.1
GENDER
Male	12.0	11.1	0.5	0.5	0.3	0.2
Female	5.1	4.9	0.1	0.1	0.0	0.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.8	8.3	0.3	0.3	0.1	0.1
White	10.0	9.6	0.3	0.3	0.2	0.1
Black or African American	3.2	2.4	0.1	0.1	0.0	0.1
American Indian or Alaska Native	19.4^b	6.8	0.1	*	*	*
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	2.9	1.8	0.0	0.3	*	0.1
Two or More Races	12.9	12.8	0.6	0.8	0.3	0.3
Hispanic or Latino	5.4	5.0	0.3	0.1	0.2^a	0.0
EDUCATION
< High School	6.5	6.0	0.2	0.3	0.0	0.3
High School Graduate	6.4	6.3	0.1	0.2	0.1	0.1
Some College	9.5	8.6	0.6	0.3	0.3	0.1
College Graduate	10.3	9.5	0.3	0.4	0.2	0.1
CURRENT EMPLOYMENT
Full-Time	10.5^a	9.5	0.4	0.3	0.2	0.1
Part-Time	9.0	8.6	0.3^a	0.0	0.2	*
Unemployed	9.1	11.6	0.3	0.9	0.3	0.2
Other¹	4.4	4.2	0.1	0.3	0.0^a	0.2

120405

Table 1.48A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	19,763	18,646	1,163	1,041	428	402
GENDER
Male	13,270	12,305	817	750	335	320
Female	6,493	6,341	346	291	93	82
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	17,891	16,743	997	927	348	367
White	16,121	15,214	892	736	307	282
Black or African American	878	700	55	63	27	38
American Indian or Alaska Native	201^a	102	12	*	2	*
Native Hawaiian or Other Pacific Islander	28	68	1	12	1	12
Asian	332	269	15^a	65	5	27
Two or More Races	330	390	21	28	7	7
Hispanic or Latino	1,873	1,903	166	113	80	35
EDUCATION
< High School	2,493	2,214	186	162	40	91
High School Graduate	4,854	4,692	274	255	89	75
Some College	5,659	5,325	466	349	169	146
College Graduate	6,757	6,416	237	275	131	90
CURRENT EMPLOYMENT
Full-Time	12,018	11,015	605	418	276	161
Part-Time	3,080	2,886	263^b	146	79	33
Unemployed	1,443	1,523	110	180	47	50
Other¹	3,222	3,222	184	297	26^b	158

120405

Table 1.48B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	8.6^a	8.0	0.5	0.4	0.2	0.2
GENDER
Male	12.0^a	11.0	0.7	0.7	0.3	0.3
Female	5.5	5.3	0.3	0.2	0.1	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.1^a	8.4	0.5	0.5	0.2	0.2
White	10.3	9.8	0.6	0.5	0.2	0.2
Black or African American	3.3	2.6	0.2	0.2	0.1	0.1
American Indian or Alaska Native	18.7^b	7.9	1.1	*	0.2	*
Native Hawaiian or Other Pacific Islander	4.3	7.9	0.1	1.4	0.1	1.4
Asian	3.2	2.4	0.1^a	0.6	0.0	0.2
Two or More Races	12.4	11.9	0.8	0.9	0.3	0.2
Hispanic or Latino	5.9	5.6	0.5	0.3	0.3	0.1
EDUCATION
< High School	7.1	6.7	0.5	0.5	0.1	0.3
High School Graduate	7.0	6.7	0.4	0.4	0.1	0.1
Some College	9.6	8.6	0.8	0.6	0.3	0.2
College Graduate	10.3	9.4	0.4	0.4	0.2	0.1
CURRENT EMPLOYMENT
Full-Time	10.5^a	9.5	0.5	0.4	0.2	0.1
Part-Time	9.3	8.9	0.8^b	0.5	0.2	0.1
Unemployed	9.7	11.2	0.7	1.3	0.3	0.4
Other¹	4.8	4.5	0.3	0.4	0.0^b	0.2

120405

Table 1.49A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	51,832	51,243	16,051^a	14,657	6,957^a	6,119
AGE
12-17	2,591	2,522	1,812	1,749	721	688
18-25	9,832^a	9,373	4,876^b	4,366	1,997^b	1,711
26 or Older	39,409	39,348	9,362	8,542	4,239	3,720
GENDER
Male	27,884	27,317	8,617^a	7,676	3,680	3,229
Female	23,948	23,926	7,434	6,981	3,277	2,891
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	46,111	45,349	13,861^b	12,503	6,020^a	5,255
White	39,745	38,737	11,671^b	10,506	5,135^a	4,399
Black or African American	3,996	4,168	1,334	1,273	602	498
American Indian or Alaska Native	328	366	129	161	55	85
Native Hawaiian or Other Pacific Islander	70	*	29	47	18	35
Asian	1,088	880	442	251	111	111
Two or More Races	884	978	257	266	99	127
Hispanic or Latino	5,721	5,894	2,189	2,154	937	864

120405

Table 1.49B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	20.4	19.9	6.3^b	5.7	2.7^b	2.4
AGE
12-17	10.6	10.1	7.4	7.0	3.0	2.8
18-25	28.9^b	27.3	14.3^b	12.7	5.9^b	5.0
26 or Older	20.2	19.8	4.8	4.3	2.2	1.9
GENDER
Male	22.6	21.9	7.0^a	6.2	3.0	2.6
Female	18.4	18.0	5.7	5.2	2.5^a	2.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	21.3	20.8	6.4^b	5.7	2.8^a	2.4
White	23.4	22.9	6.9^a	6.2	3.0^a	2.6
Black or African American	13.2	13.8	4.4	4.2	2.0	1.6
American Indian or Alaska Native	27.2	25.6	10.7	11.3	4.6	6.0
Native Hawaiian or Other Pacific Islander	9.6	*	4.0	5.0	2.4	3.7
Asian	9.5	7.1	3.9	2.0	1.0	0.9
Two or More Races	27.8	24.5	8.1	6.7	3.1	3.2
Hispanic or Latino	15.6	15.0	6.0	5.5	2.5	2.2

120405

Table 1.50A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	2,591	2,522	1,812	1,749	721	688
GENDER
Male	1,198	1,215	806	829	282	302
Female	1,392	1,307	1,006	920	440	386
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,019	1,972	1,413	1,387	555	554
White	1,509	1,425	1,095	1,036	407	405
Black or African American	341	356	206	223	92	89
American Indian or Alaska Native	22	23	15	20	4	10
Native Hawaiian or Other Pacific Islander	7	*	*	*	1	*
Asian	58	58	35	33	19	14
Two or More Races	82	98	60	72	31	35
Hispanic or Latino	572	551	399	362	166	134
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic	669	705	475	500	159	185
Female, White, Not Hispanic	840^a	720	620	535	248	220
Male, Black, Not Hispanic	148	168	81	109	37	33
Female, Black, Not Hispanic	193	188	125	114	56	56
Male, Hispanic	304	257	204	167	70	54
Female, Hispanic	268	294	195	195	96	79

120405

Table 1.50B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	10.6	10.1	7.4	7.0	3.0	2.8
GENDER
Male	9.6	9.5	6.5	6.5	2.3	2.4
Female	11.7	10.7	8.5	7.5	3.7	3.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	10.4	10.1	7.3	7.1	2.9	2.8
White	10.7	10.3	7.8	7.5	2.9	2.9
Black or African American	9.6	10.1	5.8	6.3	2.6	2.5
American Indian or Alaska Native	16.9	16.9	11.5	14.3	3.4	7.6
Native Hawaiian or Other Pacific Islander	9.7	*	*	*	1.6	*
Asian	5.5	4.8	3.3	2.7	1.8	1.1
Two or More Races	15.5	13.7	11.3	10.1	5.8	4.9
Hispanic or Latino	11.7	10.2	8.1	6.7	3.4	2.5
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic	9.3	9.9	6.6	7.0	2.2	2.6
Female, White, Not Hispanic	12.2^a	10.7	9.0	7.9	3.6	3.3
Male, Black, Not Hispanic	8.3	9.5	4.5	6.2	2.0	1.9
Female, Black, Not Hispanic	10.9	10.6	7.1	6.4	3.2	3.2
Male, Hispanic	12.0^a	9.3	8.0	6.0	2.8	2.0
Female, Hispanic	11.3	11.1	8.2	7.4	4.1	3.0

120405

Table 1.51A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	9,832^a	9,373	4,876^b	4,366	1,997^b	1,711
GENDER
Male	5,275^a	4,996	2,685^a	2,442	1,098^a	945
Female	4,558	4,377	2,191^b	1,924	899^a	766
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8,374^b	7,852	4,232^b	3,686	1,747^b	1,494
White	7,175^b	6,470	3,660^b	3,054	1,508^b	1,236
Black or African American	735	814	353	387	162	148
American Indian or Alaska Native	59	85	28	34	19	9
Native Hawaiian or Other Pacific Islander	*	*	11	*	*	*
Asian	198	245	93	91	26	37
Two or More Races	181	193	86	102	25	50
Hispanic or Latino	1,458	1,520	644	680	250	217
EDUCATION
< High School	1,706	1,614	870	766	417	351
High School Graduate	3,238	3,111	1,601	1,540	704	603
Some College	3,445	3,410	1,729	1,590	681	602
College Graduate	1,442^a	1,237	676^b	471	195	154
CURRENT EMPLOYMENT
Full-Time	3,812	3,680	1,779^a	1,565	769^b	544
Part-Time	2,745	2,553	1,414^a	1,228	484	497
Unemployed	1,352	1,340	691	674	354	317
Other¹	1,923	1,799	992	899	389	353

120405

Table 1.51B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	28.9^b	27.3	14.3^b	12.7	5.9^b	5.0
GENDER
Male	30.5	29.1	15.5^a	14.2	6.4^a	5.5
Female	27.1^a	25.6	13.0^b	11.2	5.4^a	4.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	30.4^a	28.8	15.4^b	13.5	6.4^b	5.5
White	35.3^b	33.0	18.0^b	15.6	7.4^b	6.3
Black or African American	15.1	17.3	7.3	8.2	3.3	3.1
American Indian or Alaska Native	32.2	39.7	15.4	15.9	10.5	4.4
Native Hawaiian or Other Pacific Islander	*	*	7.8	*	*	*
Asian	13.8	13.0	6.5	4.8	1.8	2.0
Two or More Races	33.1	27.2	15.7	14.4	4.6	7.1
Hispanic or Latino	22.2	21.6	9.8	9.6	3.8	3.1
EDUCATION
< High School	28.8	28.1	14.7	13.3	7.0	6.1
High School Graduate	27.7	26.6	13.7	13.2	6.0	5.2
Some College	29.6	28.5	14.8^a	13.3	5.8	5.0
College Graduate	30.0^b	25.2	14.1^b	9.6	4.1	3.1
CURRENT EMPLOYMENT
Full-Time	30.7	29.5	14.3^a	12.5	6.2^b	4.4
Part-Time	28.9	27.3	14.9^a	13.1	5.1	5.3
Unemployed	29.7	29.9	15.2	15.0	7.8	7.1
Other¹	25.4^a	22.6	13.1^a	11.3	5.1	4.4

120405

Table 1.52A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	39,409	39,348	9,362	8,542	4,239	3,720
GENDER
Male	21,411	21,106	5,125	4,406	2,300	1,981
Female	17,998	18,241	4,237	4,136	1,938	1,739
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	35,719	35,525	8,217	7,431	3,717	3,207
White	31,062	30,843	6,916	6,416	3,219	2,758
Black or African American	2,920	2,999	774	663	347	261
American Indian or Alaska Native	247	257	86	107	32	65
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	831	577	314	127	66	60
Two or More Races	621	687	111	91	43	42
Hispanic or Latino	3,690	3,823	1,146	1,111	522	513
EDUCATION
< High School	4,825	4,521	1,420	1,356	728	743
High School Graduate	10,710	10,478	2,490	2,449	1,142	1,150
Some College	11,652	11,816	2,724	2,383	1,185	1,023
College Graduate	12,222	12,533	2,728	2,355	1,184^a	805
CURRENT EMPLOYMENT
Full-Time	23,243	23,094	5,419	4,789	2,415	2,035
Part-Time	5,257	4,957	1,105	1,234	478	483
Unemployed	2,835	2,522	879	779	415	338
Other¹	8,074	8,775	1,959	1,740	930	864

120405

Table 1.52B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	20.2	19.8	4.8	4.3	2.2	1.9
GENDER
Male	22.9	22.3	5.5^a	4.7	2.5	2.1
Female	17.7	17.6	4.2	4.0	1.9	1.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	21.0	20.7	4.8	4.3	2.2	1.9
White	22.9	22.7	5.1	4.7	2.4	2.0
Black or African American	13.4	13.6	3.6	3.0	1.6	1.2
American Indian or Alaska Native	27.7	23.9	9.7	10.0	3.6	6.1
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	9.3	6.2	3.5	1.4	0.7	0.6
Two or More Races	29.5	26.7	5.3	3.6	2.0	1.6
Hispanic or Latino	14.6	14.2	4.5	4.1	2.1	1.9
EDUCATION
< High School	16.6	16.6	4.9	5.0	2.5	2.7
High School Graduate	18.6	18.1	4.3	4.2	2.0	2.0
Some College	24.5	23.8	5.7	4.8	2.5	2.1
College Graduate	20.1	19.8	4.5	3.7	1.9^a	1.3
CURRENT EMPLOYMENT
Full-Time	22.8	22.4	5.3	4.6	2.4	2.0
Part-Time	22.2	21.5	4.7	5.4	2.0	2.1
Unemployed	27.7	27.7	8.6	8.5	4.0	3.7
Other¹	13.6	14.0	3.3	2.8	1.6	1.4

120405

Table 1.53A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	49,241	48,721	14,238^a	12,908	6,236^a	5,431
GENDER
Male	26,686	26,102	7,810^a	6,848	3,398	2,926
Female	22,556	22,618	6,428	6,060	2,837	2,505
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	44,093	43,377	12,448^b	11,116	5,464^a	4,701
White	38,236	37,313	10,576^a	9,470	4,727^a	3,993
Black or African American	3,655	3,813	1,127	1,050	509	409
American Indian or Alaska Native	306	343	114	142	51	75
Native Hawaiian or Other Pacific Islander	64	*	27	43	*	34
Asian	1,030	822	407	218	92	98
Two or More Races	802	881	197	194	68	92
Hispanic or Latino	5,148	5,344	1,790	1,791	771	730
EDUCATION
< High School	6,531	6,135	2,290	2,122	1,145	1,094
High School Graduate	13,948	13,589	4,091	3,988	1,846	1,753
Some College	15,097	15,226	4,453	3,972	1,866	1,625
College Graduate	13,665	13,770	3,404^a	2,825	1,379^a	959
CURRENT EMPLOYMENT
Full-Time	27,055	26,774	7,198^a	6,354	3,185^a	2,580
Part-Time	8,003	7,510	2,519	2,462	962	980
Unemployed	4,187	3,862	1,570	1,452	769	655
Other¹	9,997	10,574	2,951	2,639	1,320	1,217

120405

Table 1.53B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	21.5	20.9	6.2^b	5.5	2.7^a	2.3
GENDER
Male	24.0	23.3	7.0^a	6.1	3.1	2.6
Female	19.1	18.7	5.4	5.0	2.4	2.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22.3	21.8	6.3^b	5.6	2.8^a	2.4
White	24.5	24.0	6.8^a	6.1	3.0^a	2.6
Black or African American	13.7	14.3	4.2	3.9	1.9	1.5
American Indian or Alaska Native	28.5	26.6	10.6	11.0	4.7	5.8
Native Hawaiian or Other Pacific Islander	9.6	*	4.0	5.0	*	3.9
Asian	9.9	7.3	3.9	1.9	0.9	0.9
Two or More Races	30.2	26.9	7.4	5.9	2.6	2.8
Hispanic or Latino	16.2	15.7	5.6	5.3	2.4	2.1
EDUCATION
< High School	18.6	18.6	6.5	6.4	3.3	3.3
High School Graduate	20.1	19.5	5.9	5.7	2.7	2.5
Some College	25.5	24.7	7.5^a	6.4	3.2	2.6
College Graduate	20.8	20.2	5.2^a	4.1	2.1^a	1.4
CURRENT EMPLOYMENT
Full-Time	23.7	23.1	6.3^a	5.5	2.8^a	2.2
Part-Time	24.1	23.2	7.6	7.6	2.9	3.0
Unemployed	28.3	28.4	10.6	10.7	5.2	4.8
Other¹	14.9	14.9	4.4	3.7	2.0	1.7

120405

Table 1.54A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	34,908	34,247	12,242^a	11,143	5,093^a	4,471
AGE
12-17	2,245	2,150	1,522	1,484	607	563
18-25	8,143^b	7,600	3,779^b	3,353	1,510^b	1,220
26 or Older	24,521	24,497	6,941	6,306	2,975	2,688
GENDER
Male	19,467	19,338	6,956^a	6,037	2,877	2,530
Female	15,441	14,908	5,286	5,106	2,215	1,940
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	30,742	29,994	10,457^a	9,435	4,350	3,838
White	25,972	25,152	8,637^a	7,803	3,649^a	3,149
Black or African American	3,214	3,284	1,097	1,069	478	433
American Indian or Alaska Native	233	217	107	115	48	66
Native Hawaiian or Other Pacific Islander	46^a	106	25	26	18	11
Asian	725	627	370	213	79	79
Two or More Races	551	608	221	209	77	101
Hispanic or Latino	4,166	4,252	1,785	1,708	743	632

120405

Table 1.54B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	13.8	13.3	4.8^b	4.3	2.0^a	1.7
AGE
12-17	9.2	8.6	6.3	5.9	2.5	2.3
18-25	23.9^b	22.2	11.1^b	9.8	4.4^b	3.6
26 or Older	12.6	12.4	3.6	3.2	1.5	1.4
GENDER
Male	15.8	15.5	5.6^b	4.8	2.3	2.0
Female	11.9	11.2	4.1	3.8	1.7	1.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14.2	13.7	4.8^b	4.3	2.0^a	1.8
White	15.3	14.9	5.1^a	4.6	2.1^a	1.9
Black or African American	10.6	10.8	3.6	3.5	1.6	1.4
American Indian or Alaska Native	19.4	15.2	8.9	8.1	4.0	4.6
Native Hawaiian or Other Pacific Islander	6.4	11.3	3.4	2.8	2.4	1.2
Asian	6.3	5.0	3.2	1.7	0.7	0.6
Two or More Races	17.3	15.2	7.0	5.2	2.4	2.5
Hispanic or Latino	11.3	10.8	4.9	4.3	2.0	1.6

120405

Table 1.55A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	2,245	2,150	1,522	1,484	607	563
GENDER
Male	1,053	1,027	688	693	246	244
Female	1,191	1,123	833	791	362	319
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,746	1,675	1,199	1,173	466	447
White	1,300	1,203	926	868	344	317
Black or African American	296	305	177	194	80	84
American Indian or Alaska Native	19	18	14	16	4	6
Native Hawaiian or Other Pacific Islander	6	*	*	*	1	*
Asian	52	49	29	27	17	12
Two or More Races	72	88	51	64	21	27
Hispanic or Latino	499	475	322	311	141	116
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic	581	605	406	427	136	144
Female, White, Not Hispanic	719^a	599	520	441	208	174
Male, Black, Not Hispanic	130	141	69	93	30	32
Female, Black, Not Hispanic	166	165	109	101	50	52
Male, Hispanic	270	207	173	127	65	48
Female, Hispanic	229	268	150	183	76	68

120405

Table 1.55B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	9.2	8.6	6.3	5.9	2.5	2.3
GENDER
Male	8.5	8.0	5.5	5.4	2.0	1.9
Female	10.0	9.2	7.0	6.5	3.0	2.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.0	8.6	6.2	6.0	2.4	2.3
White	9.2	8.7	6.6	6.3	2.4	2.3
Black or African American	8.3	8.6	5.0	5.5	2.2	2.4
American Indian or Alaska Native	14.4	13.4	10.6	11.9	3.1	4.6
Native Hawaiian or Other Pacific Islander	9.5	*	*	*	1.4	*
Asian	4.9	4.0	2.8	2.2	1.6	1.0
Two or More Races	13.6	12.2	9.7	9.0	4.0	3.8
Hispanic or Latino	10.2	8.8	6.6	5.7	2.9	2.1
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic	8.0	8.5	5.6	6.0	1.9	2.0
Female, White, Not Hispanic	10.5^a	8.9	7.6	6.5	3.0	2.6
Male, Black, Not Hispanic	7.3	8.0	3.8	5.3	1.7	1.8
Female, Black, Not Hispanic	9.4	9.3	6.1	5.7	2.8	2.9
Male, Hispanic	10.6^a	7.5	6.8^a	4.6	2.6	1.7
Female, Hispanic	9.7	10.1	6.3	6.9	3.2	2.6

120405

Table 1.56A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	8,143^b	7,600	3,779^b	3,353	1,510^b	1,220
GENDER
Male	4,540^b	4,175	2,175^b	1,888	884^b	705
Female	3,602	3,425	1,604	1,465	626^a	515
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6,939^b	6,409	3,286^b	2,811	1,304^b	1,072
White	5,936^b	5,229	2,815^b	2,290	1,109^b	871
Black or African American	633	721	292	336	132	129
American Indian or Alaska Native	44	69	26	27	17	9
Native Hawaiian or Other Pacific Islander	*	*	11	*	*	*
Asian	148	200	69	67	17	22
Two or More Races	155	159	74	79	22	34
Hispanic or Latino	1,204	1,191	493	542	206	148
EDUCATION
< High School	1,453	1,368	730	648	332	277
High School Graduate	2,791	2,646	1,296	1,258	576^a	448
Some College	2,797	2,677	1,305^a	1,115	487	391
College Graduate	1,100^a	910	448^a	332	115	104
CURRENT EMPLOYMENT
Full-Time	3,220	3,002	1,405	1,245	591^b	429
Part-Time	2,207	2,028	1,032^a	891	336	331
Unemployed	1,173	1,141	569	560	287	246
Other¹	1,543	1,430	773	657	296^a	213

120405

Table 1.56B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	23.9^b	22.2	11.1^b	9.8	4.4^b	3.6
GENDER
Male	26.3^a	24.3	12.6^b	11.0	5.1^b	4.1
Female	21.5^a	20.0	9.6	8.6	3.7^a	3.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	25.2^b	23.5	11.9^b	10.3	4.7^b	3.9
White	29.2^b	26.7	13.8^b	11.7	5.5^b	4.4
Black or African American	13.0	15.4	6.0	7.2	2.7	2.7
American Indian or Alaska Native	24.4	31.8	14.1	12.6	9.5	4.0
Native Hawaiian or Other Pacific Islander	*	*	7.8	*	*	*
Asian	10.3	10.6	4.8	3.6	1.2	1.2
Two or More Races	28.4	22.5	13.5	11.1	4.1	4.8
Hispanic or Latino	18.3	16.9	7.5	7.7	3.1^a	2.1
EDUCATION
< High School	24.5	23.8	12.3	11.3	5.6	4.8
High School Graduate	23.9	22.6	11.1	10.8	4.9^a	3.8
Some College	24.0	22.4	11.2^b	9.3	4.2^a	3.3
College Graduate	22.9^b	18.6	9.3^a	6.8	2.4	2.1
CURRENT EMPLOYMENT
Full-Time	25.9^a	24.0	11.3	10.0	4.8^b	3.4
Part-Time	23.2	21.6	10.9	9.5	3.5	3.5
Unemployed	25.7	25.4	12.5	12.5	6.3	5.5
Other¹	20.3^a	18.0	10.2^a	8.3	3.9^b	2.7

120405

Table 1.57A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	24,521	24,497	6,941	6,306	2,975	2,688
GENDER
Male	13,874	14,136	4,093	3,456	1,748	1,581
Female	10,647	10,361	2,848	2,850	1,227	1,107
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22,058	21,911	5,971	5,451	2,579	2,319
White	18,736	18,720	4,897	4,645	2,196	1,961
Black or African American	2,285	2,258	628	539	266	220
American Indian or Alaska Native	170	130	67	72	27	51
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	525	379	272	119	46	45
Two or More Races	324	361	96	65	34	39
Hispanic or Latino	2,463	2,586	970	855	395	369
EDUCATION
< High School	3,255	3,147	1,138	1,062	580	576
High School Graduate	6,743	6,946	1,842	1,901	853	920
Some College	7,377	7,388	2,150	1,759	857	690
College Graduate	7,146	7,015	1,811	1,584	686	502
CURRENT EMPLOYMENT
Full-Time	14,891	14,597	4,036	3,756	1,682	1,570
Part-Time	3,034	2,942	814	844	358	282
Unemployed	2,027	1,783	669	495	298	228
Other¹	4,569	5,174	1,421	1,210	637	607

120405

Table 1.57B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	12.6	12.4	3.6	3.2	1.5	1.4
GENDER
Male	14.8	14.9	4.4^a	3.6	1.9	1.7
Female	10.5	10.0	2.8	2.8	1.2	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	13.0	12.8	3.5	3.2	1.5	1.4
White	13.8	13.8	3.6	3.4	1.6	1.4
Black or African American	10.5	10.2	2.9	2.4	1.2	1.0
American Indian or Alaska Native	19.1	12.1	7.5	6.7	3.0	4.8
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	5.9	4.1	3.0	1.3	0.5	0.5
Two or More Races	15.4	14.0	4.6	2.5	1.6	1.5
Hispanic or Latino	9.7	9.6	3.8	3.2	1.6	1.4
EDUCATION
< High School	11.2	11.5	3.9	3.9	2.0	2.1
High School Graduate	11.7	12.0	3.2	3.3	1.5	1.6
Some College	15.5	14.9	4.5^a	3.5	1.8	1.4
College Graduate	11.7	11.1	3.0	2.5	1.1	0.8
CURRENT EMPLOYMENT
Full-Time	14.6	14.1	4.0	3.6	1.7	1.5
Part-Time	12.8	12.8	3.4	3.7	1.5	1.2
Unemployed	19.8	19.6	6.5	5.4	2.9	2.5
Other¹	7.7	8.2	2.4	1.9	1.1	1.0

120405

Table 1.58A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	32,664	32,097	10,720^a	9,659	4,485^a	3,908
GENDER
Male	18,414	18,311	6,268^b	5,344	2,632	2,286
Female	14,250	13,786	4,452	4,315	1,853	1,622
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	28,997	28,319	9,257^a	8,262	3,884	3,391
White	24,672	23,949	7,711^a	6,935	3,306^a	2,832
Black or African American	2,918	2,979	920	875	398	349
American Indian or Alaska Native	215	199	93	99	44	60
Native Hawaiian or Other Pacific Islander	40^a	94	22	22	*	11
Asian	673	578	341	186	63	67
Two or More Races	479	520	170	145	56	73
Hispanic or Latino	3,667	3,777	1,463	1,397	602	517
EDUCATION
< High School	4,709	4,515	1,868	1,710	912	852
High School Graduate	9,534	9,592	3,138	3,159	1,428	1,368
Some College	10,175	10,065	3,455^a	2,875	1,344	1,081
College Graduate	8,246	7,925	2,259	1,916	801	606
CURRENT EMPLOYMENT
Full-Time	18,111	17,599	5,441	5,001	2,273	2,000
Part-Time	5,241	4,970	1,846	1,735	694	614
Unemployed	3,201	2,923	1,238	1,055	586	475
Other¹	6,111	6,605	2,194	1,868	933	820

120405

Table 1.58B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2010 and 2011
Demographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	14.2	13.8	4.7^b	4.2	2.0^a	1.7
GENDER
Male	16.6	16.4	5.6^b	4.8	2.4	2.0
Female	12.0	11.4	3.8	3.6	1.6	1.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14.7	14.3	4.7^a	4.2	2.0^a	1.7
White	15.8	15.4	4.9^a	4.5	2.1^a	1.8
Black or African American	10.9	11.1	3.4	3.3	1.5	1.3
American Indian or Alaska Native	20.0	15.4	8.6	7.7	4.1	4.6
Native Hawaiian or Other Pacific Islander	6.0	10.9	3.4	2.6	*	1.3
Asian	6.5	5.2	3.3	1.7	0.6	0.6
Two or More Races	18.1	15.9	6.4	4.4	2.1	2.2
Hispanic or Latino	11.5	11.1	4.6	4.1	1.9	1.5
EDUCATION
< High School	13.4	13.7	5.3	5.2	2.6	2.6
High School Graduate	13.7	13.8	4.5	4.5	2.1	2.0
Some College	17.2	16.3	5.8^b	4.7	2.3^a	1.8
College Graduate	12.5	11.6	3.4	2.8	1.2	0.9
CURRENT EMPLOYMENT
Full-Time	15.9	15.2	4.8	4.3	2.0	1.7
Part-Time	15.8	15.3	5.6	5.3	2.1	1.9
Unemployed	21.6	21.5	8.4	7.8	4.0	3.5
Other¹	9.1	9.3	3.3^a	2.6	1.4	1.2

120404

Table 1.59A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	119,933	121,078	38,908	38,287	22,648	22,454
GEOGRAPHIC DIVISION
Northeast	22,990	22,550	7,360	7,263	4,421	4,319
New England	6,615	6,598	2,210	2,190	1,413	1,273
Middle Atlantic	16,375	15,952	5,150	5,073	3,007	3,046
Midwest	26,248	26,283	7,873	7,839	4,533	4,738
East North Central	18,750	18,453	5,894	5,725	3,466	3,568
West North Central	7,497	7,830	1,978	2,114	1,068	1,170
South	41,393	42,916	12,637	12,753	7,228	7,114
South Atlantic	22,273	23,350	6,957	6,871	4,038	3,716
East South Central	6,726	6,826	1,907	1,977	1,076	1,239
West South Central	12,395	12,741	3,773	3,905	2,114	2,159
West	29,302	29,329	11,038	10,432	6,466	6,283
Mountain	9,208	9,109	3,469^a	2,947	2,037^a	1,653
Pacific	20,094	20,219	7,569	7,486	4,429	4,630
COUNTY TYPE
Large Metro	66,195	65,728	21,977	21,427	12,801	12,572
Small Metro	36,587	38,181	11,858	11,965	6,827	7,007
250K - 1 Mil. Pop.	24,847	26,052	8,040	8,038	4,613	4,740
< 250K Pop.	11,739	12,129	3,818	3,927	2,214	2,267
Nonmetro	17,151	17,169	5,073	4,894	3,020	2,875
Urbanized	7,788	7,840	2,321	2,413	1,488	1,431
Less Urbanized	8,124	7,608	2,460	2,047	1,395	1,206
Completely Rural	1,239^a	1,721	293^a	434	137^a	238

120404

Table 1.59B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	47.3	47.0	15.3	14.9	8.9	8.7
GEOGRAPHIC DIVISION
Northeast	49.4	48.1	15.8	15.5	9.5	9.2
New England	54.0	53.5	18.0	17.8	11.5	10.3
Middle Atlantic	47.8	46.1	15.0	14.7	8.8	8.8
Midwest	47.4	47.2	14.2	14.1	8.2	8.5
East North Central	48.7	47.7	15.3	14.8	9.0	9.2
West North Central	44.6	46.1	11.8	12.4	6.4	6.9
South	44.5	45.1	13.6	13.4	7.8	7.5
South Atlantic	45.5	46.5	14.2	13.7	8.2	7.4
East South Central	44.6	44.6	12.6	12.9	7.1	8.1
West South Central	42.9	42.9	13.1	13.2	7.3	7.3
West	49.9	49.0	18.8	17.4	11.0	10.5
Mountain	51.1	50.2	19.2^a	16.2	11.3^a	9.1
Pacific	49.3	48.5	18.6	18.0	10.9	11.1
COUNTY TYPE
Large Metro	48.8	48.0	16.2	15.7	9.4	9.2
Small Metro	47.2	47.4	15.3	14.8	8.8	8.7
250K - 1 Mil. Pop.	48.3	47.8	15.6	14.7	9.0	8.7
< 250K Pop.	45.2	46.5	14.7	15.0	8.5	8.7
Nonmetro	42.4	42.7	12.5	12.2	7.5	7.2
Urbanized	45.6	46.7	13.6	14.4	8.7	8.5
Less Urbanized	41.3	39.7	12.5	10.7	7.1	6.3
Completely Rural	33.3^a	41.0	7.9	10.3	3.7	5.7

120404

Table 1.60A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	6,278	6,373	4,745	4,735	2,468	2,522
GEOGRAPHIC DIVISION
Northeast	1,073	1,110	840	854	479	442
New England	307	307	242	250	142	138
Middle Atlantic	767	803	598	605	337	304
Midwest	1,320	1,304	986	960	506	511
East North Central	933	910	693	663	364	368
West North Central	387	395	293	297	141	144
South	2,200	2,209	1,657	1,585	792	831
South Atlantic	1,185	1,087	894	781	418	393
East South Central	330	336	251	240	111	139
West South Central	686	786	512	563	264	298
West	1,684	1,749	1,261	1,336	690	738
Mountain	520	511	394	390	198	215
Pacific	1,163	1,238	867	946	492	523
COUNTY TYPE
Large Metro	3,353	3,403	2,571	2,521	1,405	1,314
Small Metro	2,011	2,013	1,496	1,507	757^a	864
250K - 1 Mil. Pop.	1,393	1,398	1,030	1,076	544	600
< 250K Pop.	617	615	466	432	213	265
Nonmetro	914	957	677	707	306	344
Urbanized	354	445	264^a	351	116^a	174
Less Urbanized	490	423	364	293	167	141
Completely Rural	70	89	50	63	23	28

120404

Table 1.60B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	25.8	25.5	19.5	19.0	10.1	10.1
GEOGRAPHIC DIVISION
Northeast	25.3	25.9	19.8	20.0	11.3	10.3
New England	28.1	27.6	22.1	22.4	13.0	12.4
Middle Atlantic	24.4	25.4	19.0	19.1	10.7	9.6
Midwest	24.7	24.0	18.5	17.6	9.5	9.4
East North Central	24.9	23.9	18.5	17.4	9.7	9.7
West North Central	24.3	24.1	18.4	18.2	8.9	8.8
South	24.6	23.9	18.5	17.1	8.8	9.0
South Atlantic	26.4	23.5	19.9^a	16.9	9.3	8.5
East South Central	22.8	22.8	17.4	16.2	7.7	9.4
West South Central	22.7	24.9	16.9	17.8	8.7	9.4
West	28.9	29.2	21.7	22.3	11.9	12.3
Mountain	29.1	27.8	22.0	21.2	11.1	11.7
Pacific	28.9	29.8	21.5	22.8	12.2	12.6
COUNTY TYPE
Large Metro	25.7	25.6	19.7	18.9	10.8	9.9
Small Metro	26.7	25.7	19.9	19.2	10.1	11.0
250K - 1 Mil. Pop.	27.7	26.1	20.5	20.0	10.8	11.2
< 250K Pop.	24.8	24.9	18.7	17.5	8.5^a	10.7
Nonmetro	24.1	25.0	17.9	18.5	8.1	9.0
Urbanized	23.2	26.3	17.3	20.7	7.6	10.3
Less Urbanized	25.3	23.9	18.8	16.6	8.6	8.0
Completely Rural	22.1	24.9	15.7	17.6	7.3	7.8

120404

Table 1.61A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	19,538	19,534	11,990	12,067	7,345	7,352
GEOGRAPHIC DIVISION
Northeast	3,686	3,540	2,373	2,332	1,465	1,410
New England	1,112^a	1,007	778	701	509	446
Middle Atlantic	2,573	2,533	1,596	1,631	956	964
Midwest	4,285	4,168	2,574	2,537	1,555	1,513
East North Central	2,974	2,939	1,828	1,792	1,115	1,084
West North Central	1,312	1,229	746	745	440	429
South	6,780	6,999	4,022	4,094	2,402	2,442
South Atlantic	3,497^a	3,738	2,166	2,269	1,325	1,374
East South Central	1,049	1,091	570	623	319	376
West South Central	2,234	2,169	1,285	1,202	758	692
West	4,787	4,827	3,020	3,103	1,923	1,987
Mountain	1,448	1,498	880	885	533	534
Pacific	3,339	3,330	2,140	2,219	1,390	1,453
COUNTY TYPE
Large Metro	10,405	10,500	6,587	6,708	4,030	4,179
Small Metro	6,536	6,417	3,949	3,867	2,443	2,318
250K - 1 Mil. Pop.	4,233	4,128	2,541	2,510	1,554	1,456
< 250K Pop.	2,303	2,289	1,408	1,357	890	862
Nonmetro	2,597	2,616	1,454	1,492	872	854
Urbanized	1,276	1,322	750	803	458	467
Less Urbanized	1,153	1,088	616	582	363	325
Completely Rural	168	206	88	107	51	62

120404

Table 1.61B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	57.3	56.9	35.2	35.2	21.6	21.4
GEOGRAPHIC DIVISION
Northeast	61.0	57.8	39.3	38.1	24.2	23.0
New England	68.5	62.8	47.8	43.7	31.3	27.8
Middle Atlantic	58.2	56.1	36.1	36.1	21.6	21.3
Midwest	57.2	56.8	34.3	34.6	20.7	20.6
East North Central	57.9	58.0	35.6	35.4	21.7	21.4
West North Central	55.7	54.0	31.7	32.8	18.7	18.9
South	54.6	55.5	32.4	32.5	19.3	19.4
South Atlantic	55.4	58.0	34.3	35.2	21.0	21.3
East South Central	52.8	54.3	28.7	31.0	16.1	18.7
West South Central	54.3	52.1	31.2	28.9	18.4	16.6
West	59.0	58.6	37.2	37.7	23.7	24.1
Mountain	58.0	60.6	35.3	35.8	21.4	21.6
Pacific	59.5	57.8	38.1	38.5	24.8	25.2
COUNTY TYPE
Large Metro	57.3	57.0	36.3	36.4	22.2	22.7
Small Metro	58.8	57.6	35.5	34.7	22.0	20.8
250K - 1 Mil. Pop.	60.3	58.3	36.2	35.4	22.1	20.6
< 250K Pop.	56.2	56.3	34.4	33.4	21.7	21.2
Nonmetro	54.2	55.1	30.3	31.4	18.2	18.0
Urbanized	60.4	59.9	35.5	36.4	21.7	21.2
Less Urbanized	49.5	52.0	26.4	27.8	15.6	15.5
Completely Rural	48.1	46.4	25.2	24.1	14.7	14.0

120404

Table 1.62A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	94,117	95,171	22,174	21,485	12,835	12,580
GEOGRAPHIC DIVISION
Northeast	18,231	17,900	4,147	4,077	2,476	2,467
New England	5,195	5,284	1,191	1,239	762	689
Middle Atlantic	13,036	12,616	2,956	2,838	1,714	1,778
Midwest	20,642	20,810	4,312	4,341	2,473	2,714
East North Central	14,843	14,605	3,373	3,270	1,986	2,117
West North Central	5,799	6,206	939	1,071	487	597
South	32,413	33,708	6,959	7,074	4,034	3,841
South Atlantic	17,591	18,525	3,897	3,820	2,296	1,949
East South Central	5,347	5,398	1,086	1,114	646	724
West South Central	9,475	9,786	1,976	2,139	1,092	1,168
West	22,831	22,752	6,756	5,993	3,852	3,557
Mountain	7,240	7,101	2,194^a	1,672	1,306^b	903
Pacific	15,591	15,652	4,562	4,321	2,546	2,654
COUNTY TYPE
Large Metro	52,437	51,824	12,819	12,198	7,366	7,079
Small Metro	28,040	29,751	6,413	6,591	3,627	3,825
250K - 1 Mil. Pop.	19,221	20,526	4,469	4,453	2,515	2,684
< 250K Pop.	8,819	9,225	1,944	2,138	1,112	1,140
Nonmetro	13,641	13,596	2,942	2,696	1,842	1,677
Urbanized	6,158	6,073	1,307	1,259	914	789
Less Urbanized	6,481	6,096	1,480	1,172	866	740
Completely Rural	1,001^a	1,426	155^a	265	62^a	148

120404

Table 1.62B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	48.2	48.0	11.4	10.8	6.6	6.3
GEOGRAPHIC DIVISION
Northeast	50.3	49.0	11.4	11.2	6.8	6.8
New England	54.5	55.0	12.5	12.9	8.0	7.2
Middle Atlantic	48.8	46.9	11.1	10.6	6.4	6.6
Midwest	48.6	48.5	10.1	10.1	5.8	6.3
East North Central	50.1	49.0	11.4	11.0	6.7	7.1
West North Central	45.1	47.4	7.3	8.2	3.8	4.6
South	45.3	46.0	9.7	9.6	5.6	5.2
South Atlantic	46.1	47.4	10.2	9.8	6.0	5.0
East South Central	45.9	45.7	9.3	9.4	5.5	6.1
West South Central	43.6	43.7	9.1	9.6	5.0	5.2
West	50.9	49.9	15.1	13.1	8.6	7.8
Mountain	52.7	51.3	16.0^a	12.1	9.5^b	6.5
Pacific	50.1	49.3	14.7	13.6	8.2	8.4
COUNTY TYPE
Large Metro	50.2	49.3	12.3	11.6	7.0	6.7
Small Metro	47.7	48.3	10.9	10.7	6.2	6.2
250K - 1 Mil. Pop.	48.8	48.8	11.3	10.6	6.4	6.4
< 250K Pop.	45.5	47.2	10.0	10.9	5.7	5.8
Nonmetro	42.8	43.0	9.2	8.5	5.8	5.3
Urbanized	45.8	47.1	9.7	9.8	6.8	6.1
Less Urbanized	42.1	39.8	9.6	7.7	5.6	4.8
Completely Rural	32.8^a	41.9	5.1	7.8	2.0^a	4.3

120404

Table 1.63A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	113,655	114,705	34,163	33,552	20,180	19,932
GEOGRAPHIC DIVISION
Northeast	21,917	21,440	6,520	6,409	3,941	3,877
New England	6,308	6,291	1,968	1,941	1,271	1,135
Middle Atlantic	15,609	15,149	4,552	4,468	2,670	2,742
Midwest	24,927	24,978	6,886	6,878	4,028	4,227
East North Central	17,817	17,543	5,201	5,062	3,101	3,201
West North Central	7,111	7,435	1,685	1,817	927	1,026
South	39,193	40,707	10,980	11,168	6,436	6,283
South Atlantic	21,088	22,263	6,063	6,089	3,621	3,323
East South Central	6,396	6,489	1,656	1,737	965	1,100
West South Central	11,709	11,955	3,262	3,342	1,850	1,861
West	27,618	27,579	9,776	9,096	5,775	5,544
Mountain	8,688	8,598	3,075^a	2,557	1,839^a	1,438
Pacific	18,930	18,981	6,702	6,540	3,936	4,106
COUNTY TYPE
Large Metro	62,842	62,324	19,406	18,906	11,395	11,258
Small Metro	34,576	36,168	10,362	10,458	6,070	6,143
250K - 1 Mil. Pop.	23,454	24,654	7,011	6,963	4,068	4,140
< 250K Pop.	11,122	11,514	3,352	3,495	2,002	2,003
Nonmetro	16,238	16,212	4,396	4,188	2,714	2,531
Urbanized	7,434	7,395	2,057	2,062	1,372	1,257
Less Urbanized	7,634	7,184	2,096	1,754	1,228	1,064
Completely Rural	1,169^a	1,633	243^a	372	114^a	210

120404

Table 1.63B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	49.6	49.3	14.9	14.4	8.8	8.6
GEOGRAPHIC DIVISION
Northeast	51.8	50.3	15.4	15.0	9.3	9.1
New England	56.5	56.1	17.6	17.3	11.4	10.1
Middle Atlantic	50.1	48.2	14.6	14.2	8.6	8.7
Midwest	49.8	49.7	13.8	13.7	8.1	8.4
East North Central	51.2	50.3	14.9	14.5	8.9	9.2
West North Central	46.7	48.4	11.1	11.8	6.1	6.7
South	46.7	47.4	13.1	13.0	7.7	7.3
South Atlantic	47.4	48.9	13.6	13.4	8.1	7.3
East South Central	46.9	46.9	12.1	12.6	7.1	8.0
West South Central	45.3	45.1	12.6	12.6	7.2	7.0
West	52.2	51.2	18.5	16.9	10.9	10.3
Mountain	53.5	52.7	18.9^a	15.7	11.3^a	8.8
Pacific	51.6	50.6	18.3	17.4	10.7	10.9
COUNTY TYPE
Large Metro	51.2	50.5	15.8	15.3	9.3	9.1
Small Metro	49.4	49.7	14.8	14.4	8.7	8.4
250K - 1 Mil. Pop.	50.5	50.2	15.1	14.2	8.8	8.4
< 250K Pop.	47.4	48.7	14.3	14.8	8.5	8.5
Nonmetro	44.3	44.6	12.0	11.5	7.4	7.0
Urbanized	47.8	49.0	13.2	13.7	8.8	8.3
Less Urbanized	43.1	41.3	11.8	10.1	6.9	6.1
Completely Rural	34.3^a	42.5	7.1	9.7	3.3	5.5

120404

Table 1.64A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	106,613	107,842	29,301	29,739	17,409	18,071
GEOGRAPHIC DIVISION
Northeast	21,091	20,362	5,808	5,864	3,471	3,576
New England	6,140	5,916	1,831	1,830	1,153	1,096
Middle Atlantic	14,951	14,446	3,977	4,034	2,317	2,480
Midwest	23,357	23,534	5,989	6,138	3,563	3,796
East North Central	16,612	16,611	4,396	4,504	2,666	2,877
West North Central	6,746	6,923	1,593	1,634	897	919
South	36,311	37,899	9,044	9,412	5,256	5,465
South Atlantic	19,793	20,787	5,074	5,195	2,914	2,961
East South Central	5,746	5,996	1,313	1,440	745^a	960
West South Central	10,772	11,116	2,657	2,777	1,597	1,544
West	25,854	26,046	8,460	8,326	5,118	5,234
Mountain	8,039	7,868	2,584^a	2,201	1,521	1,332
Pacific	17,815	18,178	5,876	6,125	3,597	3,901
COUNTY TYPE
Large Metro	59,003	58,821	16,653	16,927	9,785	10,313
Small Metro	32,371	33,907	8,826	9,098	5,285	5,531
250K - 1 Mil. Pop.	22,125	23,082	5,929	6,188	3,540	3,740
< 250K Pop.	10,246	10,825	2,897	2,910	1,744	1,790
Nonmetro	15,239	15,114	3,822	3,715	2,339	2,227
Urbanized	6,899	6,868	1,756	1,855	1,177	1,120
Less Urbanized	7,258	6,738	1,840	1,549	1,062	931
Completely Rural	1,081^a	1,508	227	310	100^a	177

120404

Table 1.64B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	42.0	41.9	11.6	11.5	6.9	7.0
GEOGRAPHIC DIVISION
Northeast	45.3	43.4	12.5	12.5	7.5	7.6
New England	50.1	48.0	14.9	14.8	9.4	8.9
Middle Atlantic	43.6	41.8	11.6	11.7	6.8	7.2
Midwest	42.2	42.3	10.8	11.0	6.4	6.8
East North Central	43.1	42.9	11.4	11.6	6.9	7.4
West North Central	40.1	40.7	9.5	9.6	5.3	5.4
South	39.1	39.8	9.7	9.9	5.7	5.7
South Atlantic	40.4	41.4	10.4	10.4	5.9	5.9
East South Central	38.1	39.2	8.7	9.4	4.9	6.3
West South Central	37.3	37.4	9.2	9.4	5.5	5.2
West	44.0	43.5	14.4	13.9	8.7	8.7
Mountain	44.6	43.3	14.3^a	12.1	8.4	7.3
Pacific	43.7	43.6	14.4	14.7	8.8	9.4
COUNTY TYPE
Large Metro	43.5	43.0	12.3	12.4	7.2	7.5
Small Metro	41.8	42.1	11.4	11.3	6.8	6.9
250K - 1 Mil. Pop.	43.0	42.4	11.5	11.4	6.9	6.9
< 250K Pop.	39.5	41.5	11.2	11.2	6.7	6.9
Nonmetro	37.7	37.6	9.4	9.2	5.8	5.5
Urbanized	40.4	40.9	10.3	11.0	6.9	6.7
Less Urbanized	36.9	35.1	9.4	8.1	5.4	4.9
Completely Rural	29.0^a	35.9	6.1	7.4	2.7	4.2

120404

Table 1.65A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	4,157	4,378	3,414	3,553	1,802	1,967
GEOGRAPHIC DIVISION
Northeast	742	784	644	657	397	362
New England	227	244	192	219	119	129
Middle Atlantic	515	540	453	438	278	233
Midwest	836	855	676	692	358	382
East North Central	572	601	470	483	247	279
West North Central	263	254	206	209	111	102
South	1,428	1,435	1,151	1,144	549	621
South Atlantic	773	732	634	596	302	312
East South Central	197	212	157	170	68^a	102
West South Central	459	490	360	379	180	207
West	1,151^a	1,304	942	1,060	497^a	602
Mountain	364	376	291	312	135^a	178
Pacific	787^a	928	651	748	363	424
COUNTY TYPE
Large Metro	2,208	2,329	1,859	1,896	1,020	1,044
Small Metro	1,364	1,444	1,083	1,168	560^a	682
250K - 1 Mil. Pop.	944	1,015	761	838	424	477
< 250K Pop.	420	428	322	330	135^b	205
Nonmetro	585	605	472	490	222	242
Urbanized	218^b	314	178^b	265	84^a	131
Less Urbanized	327^a	236	262^a	187	123	91
Completely Rural	40	55	31	37	15	20

120404

Table 1.65B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	17.1	17.5	14.0	14.2	7.4	7.9
GEOGRAPHIC DIVISION
Northeast	17.5	18.3	15.2	15.4	9.4	8.5
New England	20.7	21.9	17.5	19.6	10.9	11.6
Middle Atlantic	16.4	17.1	14.4	13.9	8.9	7.4
Midwest	15.7	15.7	12.7	12.7	6.7	7.0
East North Central	15.3	15.8	12.6	12.7	6.6	7.3
West North Central	16.5	15.5	13.0	12.7	7.0	6.2
South	15.9	15.5	12.9	12.4	6.1	6.7
South Atlantic	17.2	15.8	14.1	12.9	6.7	6.8
East South Central	13.6	14.4	10.9	11.5	4.7^a	6.9
West South Central	15.2	15.5	11.9	12.0	6.0	6.6
West	19.8	21.8	16.2	17.7	8.5	10.1
Mountain	20.4	20.4	16.3	17.0	7.5	9.7
Pacific	19.5	22.3	16.1	18.0	9.0	10.2
COUNTY TYPE
Large Metro	16.9	17.5	14.3	14.2	7.8	7.8
Small Metro	18.1	18.4	14.4	14.9	7.4^a	8.7
250K - 1 Mil. Pop.	18.7	18.9	15.1	15.6	8.4	8.9
< 250K Pop.	16.9	17.3	13.0	13.3	5.4^b	8.3
Nonmetro	15.5	15.8	12.5	12.8	5.9	6.3
Urbanized	14.3^a	18.6	11.7^a	15.7	5.5^a	7.8
Less Urbanized	16.8	13.3	13.5	10.6	6.3	5.1
Completely Rural	12.7	15.3	9.8	10.5	4.8	5.7

120404

Table 1.66A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	17,529	17,796	10,215	10,554	6,313	6,526
GEOGRAPHIC DIVISION
Northeast	3,382	3,267	2,068	2,112	1,285	1,296
New England	1,043^a	944	700	649	452	416
Middle Atlantic	2,339	2,323	1,368	1,463	833	880
Midwest	3,869	3,801	2,218	2,218	1,344	1,337
East North Central	2,673	2,679	1,562	1,579	954	955
West North Central	1,196	1,123	655	639	390	383
South	5,937^a	6,271	3,312	3,485	2,034	2,086
South Atlantic	3,138^a	3,394	1,869	2,011	1,152	1,213
East South Central	879	978	453	494	255	309
West South Central	1,920	1,898	990	981	627	564
West	4,341	4,457	2,617	2,738	1,649	1,807
Mountain	1,286	1,357	729	752	439	476
Pacific	3,055	3,100	1,888	1,986	1,210	1,330
COUNTY TYPE
Large Metro	9,387	9,643	5,695	5,967	3,493	3,757
Small Metro	5,851	5,818	3,314	3,333	2,091	2,028
250K - 1 Mil. Pop.	3,801	3,755	2,150	2,172	1,331	1,304
< 250K Pop.	2,050	2,063	1,165	1,161	760	725
Nonmetro	2,292	2,334	1,206	1,255	728	740
Urbanized	1,152	1,186	643	673	393	414
Less Urbanized	996	957	491	482	290	270
Completely Rural	143	191	72	100	45	56

120404

Table 1.66B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	51.4	51.9	30.0	30.8	18.5	19.0
GEOGRAPHIC DIVISION
Northeast	56.0	53.4	34.2	34.5	21.3	21.2
New England	64.2	58.8	43.1	40.4	27.8	25.9
Middle Atlantic	52.9	51.4	31.0	32.4	18.8	19.5
Midwest	51.6	51.8	29.6	30.2	17.9	18.2
East North Central	52.0	52.9	30.4	31.2	18.6	18.8
West North Central	50.8	49.3	27.8	28.1	16.6	16.8
South	47.8	49.7	26.7	27.6	16.4	16.5
South Atlantic	49.7	52.7	29.6	31.2	18.2	18.8
East South Central	44.2	48.7	22.8	24.6	12.9	15.4
West South Central	46.7	45.6	24.1	23.6	15.2	13.6
West	53.5	54.1	32.3	33.3	20.3	21.9
Mountain	51.5	54.9	29.2	30.5	17.6	19.3
Pacific	54.4	53.8	33.6	34.5	21.6	23.1
COUNTY TYPE
Large Metro	51.7	52.4	31.4	32.4	19.2	20.4
Small Metro	52.6	52.2	29.8	29.9	18.8	18.2
250K - 1 Mil. Pop.	54.1	53.0	30.6	30.7	19.0	18.4
< 250K Pop.	50.0	50.8	28.4	28.6	18.6	17.8
Nonmetro	47.8	49.2	25.2	26.4	15.2	15.6
Urbanized	54.6	53.7	30.4	30.5	18.6	18.7
Less Urbanized	42.7	45.7	21.1	23.0	12.4	12.9
Completely Rural	41.0	43.1	20.7	22.4	13.0	12.7

120404

Table 1.67A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	84,927	85,668	15,672	15,632	9,294	9,578
GEOGRAPHIC DIVISION
Northeast	16,967	16,311	3,095	3,094	1,789	1,918
New England	4,871	4,728	939	962	582	551
Middle Atlantic	12,096	11,583	2,156	2,132	1,207	1,367
Midwest	18,653	18,878	3,095	3,228	1,860	2,078
East North Central	13,366	13,332	2,364	2,442	1,464	1,643
West North Central	5,286	5,546	732	786	396	434
South	28,945	30,194	4,580	4,782	2,673	2,758
South Atlantic	15,882	16,661	2,571	2,588	1,460	1,435
East South Central	4,671	4,806	703	777	422	550
West South Central	8,393	8,727	1,306	1,417	791	773
West	20,362	20,285	4,901	4,527	2,972	2,825
Mountain	6,389	6,135	1,564^a	1,136	948^a	678
Pacific	13,972	14,150	3,337	3,391	2,025	2,147
COUNTY TYPE
Large Metro	47,408	46,848	9,099	9,064	5,272	5,512
Small Metro	25,156	26,645	4,429	4,597	2,634	2,821
250K - 1 Mil. Pop.	17,381	18,311	3,019	3,177	1,785	1,960
< 250K Pop.	7,776	8,334	1,410	1,419	849	861
Nonmetro	12,363	12,175	2,144	1,970	1,389	1,245
Urbanized	5,530	5,368	935	917	700	575
Less Urbanized	5,935	5,545	1,086	880	649	570
Completely Rural	898^a	1,262	123	173	39^a	100

120404

Table 1.67B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	43.5	43.2	8.0	7.9	4.8	4.8
GEOGRAPHIC DIVISION
Northeast	46.8	44.7	8.5	8.5	4.9	5.3
New England	51.1	49.2	9.9	10.0	6.1	5.7
Middle Atlantic	45.3	43.1	8.1	7.9	4.5	5.1
Midwest	43.9	44.0	7.3	7.5	4.4	4.8
East North Central	45.1	44.7	8.0	8.2	4.9	5.5
West North Central	41.1	42.4	5.7	6.0	3.1	3.3
South	40.4	41.2	6.4	6.5	3.7	3.8
South Atlantic	41.6	42.6	6.7	6.6	3.8	3.7
East South Central	40.1	40.7	6.0	6.6	3.6	4.7
West South Central	38.6	39.0	6.0	6.3	3.6	3.5
West	45.4	44.5	10.9	9.9	6.6	6.2
Mountain	46.5	44.3	11.4^a	8.2	6.9^a	4.9
Pacific	44.9	44.6	10.7	10.7	6.5	6.8
COUNTY TYPE
Large Metro	45.4	44.6	8.7	8.6	5.0	5.2
Small Metro	42.8	43.2	7.5	7.5	4.5	4.6
250K - 1 Mil. Pop.	44.1	43.5	7.7	7.6	4.5	4.7
< 250K Pop.	40.1	42.6	7.3	7.3	4.4	4.4
Nonmetro	38.8	38.5	6.7	6.2	4.4	3.9
Urbanized	41.1	41.6	7.0	7.1	5.2	4.5
Less Urbanized	38.6	36.2	7.1	5.7	4.2	3.7
Completely Rural	29.4^a	37.1	4.0	5.1	1.3^a	2.9

120404

Table 1.68A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	102,456	103,464	25,887	26,186	15,607	16,103
GEOGRAPHIC DIVISION
Northeast	20,349	19,578	5,164	5,207	3,074	3,214
New England	5,914	5,672	1,639	1,611	1,034	967
Middle Atlantic	14,436	13,906	3,524	3,596	2,039	2,247
Midwest	22,522	22,679	5,313	5,446	3,205	3,415
East North Central	16,039	16,010	3,926	4,021	2,419	2,598
West North Central	6,483	6,669	1,387	1,425	786	817
South	34,882	36,465	7,892	8,268	4,707	4,844
South Atlantic	19,020	20,055	4,440	4,599	2,613	2,649
East South Central	5,549	5,784	1,156	1,271	677	858
West South Central	10,313	10,625	2,297	2,398	1,417	1,337
West	24,703	24,742	7,518	7,265	4,621	4,631
Mountain	7,675	7,492	2,293^a	1,888	1,386	1,154
Pacific	17,028	17,250	5,225	5,377	3,235	3,477
COUNTY TYPE
Large Metro	56,795	56,492	14,794	15,031	8,765	9,269
Small Metro	31,007	32,463	7,743	7,930	4,725	4,849
250K - 1 Mil. Pop.	21,181	22,066	5,168	5,349	3,116	3,264
< 250K Pop.	9,826	10,397	2,575	2,580	1,609	1,585
Nonmetro	14,655	14,509	3,350	3,225	2,117	1,985
Urbanized	6,682	6,554	1,577	1,590	1,093	989
Less Urbanized	6,932	6,502	1,578	1,363	939	840
Completely Rural	1,041^a	1,453	195	273	85^a	157

120404

Table 1.68B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	44.7	44.5	11.3	11.3	6.8	6.9
GEOGRAPHIC DIVISION
Northeast	48.1	45.9	12.2	12.2	7.3	7.5
New England	53.0	50.6	14.7	14.4	9.3	8.6
Middle Atlantic	46.3	44.3	11.3	11.4	6.5	7.2
Midwest	45.0	45.1	10.6	10.8	6.4	6.8
East North Central	46.1	45.9	11.3	11.5	7.0	7.4
West North Central	42.6	43.4	9.1	9.3	5.2	5.3
South	41.5	42.4	9.4	9.6	5.6	5.6
South Atlantic	42.7	44.0	10.0	10.1	5.9	5.8
East South Central	40.7	41.8	8.5	9.2	5.0	6.2
West South Central	39.9	40.0	8.9	9.0	5.5	5.0
West	46.6	46.0	14.2	13.5	8.7	8.6
Mountain	47.2	45.9	14.1^a	11.6	8.5	7.1
Pacific	46.4	46.0	14.2	14.3	8.8	9.3
COUNTY TYPE
Large Metro	46.3	45.7	12.1	12.2	7.1	7.5
Small Metro	44.3	44.6	11.1	10.9	6.8	6.7
250K - 1 Mil. Pop.	45.6	44.9	11.1	10.9	6.7	6.6
< 250K Pop.	41.8	44.0	11.0	10.9	6.9	6.7
Nonmetro	40.0	39.9	9.1	8.9	5.8	5.5
Urbanized	43.0	43.4	10.1	10.5	7.0	6.5
Less Urbanized	39.1	37.4	8.9	7.8	5.3	4.8
Completely Rural	30.6^a	37.8	5.7	7.1	2.5	4.1

120404

Table 1.69A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	37,361	36,921	4,533^a	3,857	1,472	1,369
GEOGRAPHIC DIVISION
Northeast	7,305	6,989	996	921	366	360
New England	2,046	2,101	282	243	126	86
Middle Atlantic	5,259	4,888	714	678	240	273
Midwest	6,983	6,981	747	729	205	267
East North Central	4,870	5,076	573	567	169	218
West North Central	2,113	1,905	174	162	36	49
South	12,071	12,174	1,522^a	1,186	516	399
South Atlantic	6,672	6,627	897^a	631	301	182
East South Central	1,488^b	2,006	202	158	69	64
West South Central	3,911	3,541	423	397	146	154
West	11,002	10,777	1,268	1,020	385	344
Mountain	3,434	3,351	395	287	84	103
Pacific	7,569	7,426	873	732	301	241
COUNTY TYPE
Large Metro	20,613	20,358	2,715	2,379	920	864
Small Metro	11,435	11,795	1,374^a	1,134	441	399
250K - 1 Mil. Pop.	7,633	8,316	935	765	330	253
< 250K Pop.	3,802	3,479	438	369	111	146
Nonmetro	5,313	4,768	444	343	111	106
Urbanized	2,476	2,098	207	197	64	66
Less Urbanized	2,519	2,135	224^a	118	46	29
Completely Rural	318^a	535	13	29	2	10

120404

Table 1.69B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	14.7	14.3	1.8^b	1.5	0.6	0.5
GEOGRAPHIC DIVISION
Northeast	15.7	14.9	2.1	2.0	0.8	0.8
New England	16.7	17.0	2.3	2.0	1.0	0.7
Middle Atlantic	15.3	14.1	2.1	2.0	0.7	0.8
Midwest	12.6	12.5	1.4	1.3	0.4	0.5
East North Central	12.6	13.1	1.5	1.5	0.4	0.6
West North Central	12.6	11.2	1.0	1.0	0.2	0.3
South	13.0	12.8	1.6^a	1.2	0.6	0.4
South Atlantic	13.6	13.2	1.8^a	1.3	0.6	0.4
East South Central	9.9^a	13.1	1.3	1.0	0.5	0.4
West South Central	13.5	11.9	1.5	1.3	0.5	0.5
West	18.7	18.0	2.2	1.7	0.7	0.6
Mountain	19.0	18.5	2.2	1.6	0.5	0.6
Pacific	18.6	17.8	2.1	1.8	0.7	0.6
COUNTY TYPE
Large Metro	15.2	14.9	2.0	1.7	0.7	0.6
Small Metro	14.8	14.6	1.8^a	1.4	0.6	0.5
250K - 1 Mil. Pop.	14.8	15.3	1.8^a	1.4	0.6	0.5
< 250K Pop.	14.6	13.3	1.7	1.4	0.4	0.6
Nonmetro	13.1	11.9	1.1	0.9	0.3	0.3
Urbanized	14.5	12.5	1.2	1.2	0.4	0.4
Less Urbanized	12.8	11.1	1.1^a	0.6	0.2	0.2
Completely Rural	8.5	12.7	0.4	0.7	0.0	0.2

120404

Table 1.70A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	363	337	239	229	60	67
GEOGRAPHIC DIVISION
Northeast	42	52	31	38	9	10
New England	15	23	8	20	2	7
Middle Atlantic	27	29	24	18	7	3
Midwest	62	61	42	42	9	18
East North Central	35	47	22	34	5	15
West North Central	27	15	20^a	8	4	3
South	129	112	84	71	24	17
South Atlantic	43	52	27	30	11	8
East South Central	16	13	13	10	4	1
West South Central	70	48	45	31	8	7
West	130	111	82	77	19	23
Mountain	27	25	15	19	3	6
Pacific	103	86	66	59	16	17
COUNTY TYPE
Large Metro	189	168	133	121	30	41
Small Metro	128	125	72	79	16	18
250K - 1 Mil. Pop.	95	94	56	60	13	16
< 250K Pop.	33	31	16	20	3	2
Nonmetro	46	44	34	29	15	9
Urbanized	15	23	14	14	7	2
Less Urbanized	28	16	19	13	8	6
Completely Rural	3	4	2	2	*	*

120404

Table 1.70B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	1.5	1.3	1.0	0.9	0.2	0.3
GEOGRAPHIC DIVISION
Northeast	1.0	1.2	0.7	0.9	0.2	0.2
New England	1.4	2.1	0.7	1.8	0.1	0.6
Middle Atlantic	0.9	0.9	0.7	0.6	0.2	0.1
Midwest	1.2	1.1	0.8	0.8	0.2	0.3
East North Central	0.9	1.2	0.6	0.9	0.1	0.4
West North Central	1.7^a	0.9	1.2^a	0.5	0.3	0.2
South	1.4	1.2	0.9	0.8	0.3	0.2
South Atlantic	1.0	1.1	0.6	0.7	0.2	0.2
East South Central	1.1	0.9	0.9	0.7	0.3	0.1
West South Central	2.3	1.5	1.5	1.0	0.3	0.2
West	2.2	1.9	1.4	1.3	0.3	0.4
Mountain	1.5	1.4	0.9	1.0	0.1	0.3
Pacific	2.6	2.1	1.6	1.4	0.4	0.4
COUNTY TYPE
Large Metro	1.4	1.3	1.0	0.9	0.2	0.3
Small Metro	1.7	1.6	1.0	1.0	0.2	0.2
250K - 1 Mil. Pop.	1.9	1.7	1.1	1.1	0.3	0.3
< 250K Pop.	1.3	1.3	0.6	0.8	0.1	0.1
Nonmetro	1.2	1.1	0.9	0.8	0.4	0.2
Urbanized	1.0	1.4	0.9	0.9	0.5	0.1
Less Urbanized	1.4	0.9	1.0	0.7	0.4	0.3
Completely Rural	1.0	1.2	0.5	0.5	*	*

120404

Table 1.71A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	4,568^a	4,253	1,593	1,563	503	464
GEOGRAPHIC DIVISION
Northeast	807	728	344	314	143^a	93
New England	259	249	107	104	45^a	23
Middle Atlantic	548	479	237	209	97	69
Midwest	942^a	823	295	284	78	85
East North Central	638^a	539	217	203	60	54
West North Central	304	284	78	81	18	30
South	1,552	1,389	467	471	121	142
South Atlantic	765	656	264	254	74	75
East South Central	181	238	45	53	13	18
West South Central	607^a	495	159	164	34	49
West	1,267	1,313	487	494	161	145
Mountain	401	434	137	160	40	37
Pacific	866	880	350	334	121	108
COUNTY TYPE
Large Metro	2,310	2,236	835	891	277	268
Small Metro	1,629^a	1,444	573	499	171	154
250K - 1 Mil. Pop.	1,037	953	363	344	116	100
< 250K Pop.	592	491	210	155	55	54
Nonmetro	629	573	186	173	54	42
Urbanized	317	312	101	100	30	26
Less Urbanized	265	215	82	55	23	13
Completely Rural	48	45	2^a	18	1	3

120404

Table 1.71B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	13.4^a	12.4	4.7	4.6	1.5	1.4
GEOGRAPHIC DIVISION
Northeast	13.3	11.9	5.7	5.1	2.4^a	1.5
New England	16.0	15.5	6.6	6.5	2.8^a	1.4
Middle Atlantic	12.4	10.6	5.4	4.6	2.2	1.5
Midwest	12.6	11.2	3.9	3.9	1.0	1.2
East North Central	12.4^a	10.6	4.2	4.0	1.2	1.1
West North Central	12.9	12.5	3.3	3.6	0.8	1.3
South	12.5^a	11.0	3.8	3.7	1.0	1.1
South Atlantic	12.1	10.2	4.2	3.9	1.2	1.2
East South Central	9.1	11.8	2.2	2.7	0.7	0.9
West South Central	14.7^a	11.9	3.9	3.9	0.8	1.2
West	15.6	16.0	6.0	6.0	2.0	1.8
Mountain	16.0	17.6	5.5	6.5	1.6	1.5
Pacific	15.4	15.3	6.2	5.8	2.2	1.9
COUNTY TYPE
Large Metro	12.7	12.1	4.6	4.8	1.5	1.5
Small Metro	14.6^a	13.0	5.2	4.5	1.5	1.4
250K - 1 Mil. Pop.	14.8	13.5	5.2	4.9	1.7	1.4
< 250K Pop.	14.4^a	12.1	5.1	3.8	1.3	1.3
Nonmetro	13.1	12.1	3.9	3.7	1.1	0.9
Urbanized	15.0	14.1	4.8	4.5	1.4	1.2
Less Urbanized	11.4	10.3	3.5	2.6	1.0	0.6
Completely Rural	13.7	10.2	0.7^a	3.9	0.3	0.6

120404

Table 1.72A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	32,430	32,332	2,700^b	2,065	909	838
GEOGRAPHIC DIVISION
Northeast	6,456	6,209	621	569	214	257
New England	1,771	1,829	167	119	79	56
Middle Atlantic	4,684	4,380	454	451	135	201
Midwest	5,979	6,097	410	403	118	165
East North Central	4,198	4,490	334	330	104	149
West North Central	1,782	1,607	76	73	14	16
South	10,390	10,673	970^a	644	371	241
South Atlantic	5,864	5,919	606^a	346	216	99
East South Central	1,292^a	1,756	144	95	52	44
West South Central	3,234	2,999	220	203	104	98
West	9,606	9,353	699	448	205	176
Mountain	3,006	2,893	242^a	108	41	60
Pacific	6,600	6,460	457	340	164	116
COUNTY TYPE
Large Metro	18,114	17,954	1,747	1,367	612	556
Small Metro	9,678	10,226	729	556	254	227
250K - 1 Mil. Pop.	6,501	7,270	516	361	200	137
< 250K Pop.	3,177	2,956	213	195	54	90
Nonmetro	4,638	4,152	224	141	42	55
Urbanized	2,144	1,763	92	82	27	39
Less Urbanized	2,227	1,903	123	50	15	10
Completely Rural	268^a	485	9	9	1	6

120404

Table 1.72B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	16.6	16.3	1.4^b	1.0	0.5	0.4
GEOGRAPHIC DIVISION
Northeast	17.8	17.0	1.7	1.6	0.6	0.7
New England	18.6	19.0	1.8	1.2	0.8	0.6
Middle Atlantic	17.5	16.3	1.7	1.7	0.5	0.7
Midwest	14.1	14.2	1.0	0.9	0.3	0.4
East North Central	14.2	15.1	1.1	1.1	0.4	0.5
West North Central	13.9	12.3	0.6	0.6	0.1	0.1
South	14.5	14.6	1.4^a	0.9	0.5	0.3
South Atlantic	15.4	15.1	1.6^a	0.9	0.6	0.3
East South Central	11.1^a	14.9	1.2	0.8	0.4	0.4
West South Central	14.9	13.4	1.0	0.9	0.5	0.4
West	21.4	20.5	1.6^a	1.0	0.5	0.4
Mountain	21.9	20.9	1.8^a	0.8	0.3	0.4
Pacific	21.2	20.3	1.5	1.1	0.5	0.4
COUNTY TYPE
Large Metro	17.3	17.1	1.7	1.3	0.6	0.5
Small Metro	16.5	16.6	1.2	0.9	0.4	0.4
250K - 1 Mil. Pop.	16.5	17.3	1.3^a	0.9	0.5	0.3
< 250K Pop.	16.4	15.1	1.1	1.0	0.3	0.5
Nonmetro	14.6	13.1	0.7	0.4	0.1	0.2
Urbanized	16.0	13.7	0.7	0.6	0.2	0.3
Less Urbanized	14.5	12.4	0.8	0.3	0.1	0.1
Completely Rural	8.8^a	14.3	0.3	0.3	0.0	0.2

120404

Table 1.73A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	36,998	36,584	4,294^a	3,628	1,412	1,302
GEOGRAPHIC DIVISION
Northeast	7,262	6,937	965	883	357	349
New England	2,031	2,077	274	223	125	79
Middle Atlantic	5,232	4,859	691	660	232	270
Midwest	6,922	6,920	705	687	196	249
East North Central	4,836	5,030	551	533	164	203
West North Central	2,086	1,891	154	154	32	46
South	11,942	12,062	1,437^a	1,116	493	383
South Atlantic	6,629	6,575	870^a	601	290	174
East South Central	1,473^b	1,993	189	149	65	62
West South Central	3,841	3,494	378	367	138	147
West	10,872	10,666	1,186	942	366	321
Mountain	3,407	3,326	379	268	81	97
Pacific	7,465	7,340	807	674	285	224
COUNTY TYPE
Large Metro	20,424	20,190	2,582	2,258	889	824
Small Metro	11,307	11,670	1,302^a	1,055	425	381
250K - 1 Mil. Pop.	7,538	8,222	879	706	317	237
< 250K Pop.	3,769	3,448	423	349	109	145
Nonmetro	5,267	4,725	410	315	97	97
Urbanized	2,461	2,075	193	183	57	65
Less Urbanized	2,491	2,119	205^a	105	38	23
Completely Rural	315^a	531	11	27	2	9

120404

Table 1.73B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	16.1	15.7	1.9^b	1.6	0.6	0.6
GEOGRAPHIC DIVISION
Northeast	17.2	16.3	2.3	2.1	0.8	0.8
New England	18.2	18.5	2.5	2.0	1.1	0.7
Middle Atlantic	16.8	15.5	2.2	2.1	0.7	0.9
Midwest	13.8	13.8	1.4	1.4	0.4	0.5
East North Central	13.9	14.4	1.6	1.5	0.5	0.6
West North Central	13.7	12.3	1.0	1.0	0.2	0.3
South	14.2	14.0	1.7^a	1.3	0.6	0.4
South Atlantic	14.9	14.4	2.0^a	1.3	0.7	0.4
East South Central	10.8^a	14.4	1.4	1.1	0.5	0.5
West South Central	14.9	13.2	1.5	1.4	0.5	0.6
West	20.5	19.8	2.2	1.7	0.7	0.6
Mountain	21.0	20.4	2.3	1.6	0.5	0.6
Pacific	20.3	19.6	2.2	1.8	0.8	0.6
COUNTY TYPE
Large Metro	16.6	16.3	2.1	1.8	0.7	0.7
Small Metro	16.2	16.0	1.9^a	1.4	0.6	0.5
250K - 1 Mil. Pop.	16.2	16.7	1.9^a	1.4	0.7	0.5
< 250K Pop.	16.1	14.6	1.8	1.5	0.5	0.6
Nonmetro	14.4	13.0	1.1	0.9	0.3	0.3
Urbanized	15.8	13.7	1.2	1.2	0.4	0.4
Less Urbanized	14.1	12.2	1.2^a	0.6	0.2	0.1
Completely Rural	9.3	13.8	0.3	0.7	0.0	0.2

120404

Table 1.74A – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	9,208^a	8,214	885^a	625	378^a	228
GEOGRAPHIC DIVISION
Northeast	1,643	1,388	213	138	101	63
New England	521	353	83	46	57	21
Middle Atlantic	1,122	1,035	130	93	44	42
Midwest	1,757	1,698	185	164	79	76
East North Central	1,126	1,247	160	137	64	66
West North Central	631^a	451	25	27	15	9
South	3,329	2,870	342	245	165	76
South Atlantic	1,975	1,578	153	136	62	43
East South Central	542	473	79	55	39	9
West South Central	813	819	110	53	64	23
West	2,479	2,258	144	78	33	14
Mountain	844	692	51	22	9	7
Pacific	1,635	1,566	93	57	24	7
COUNTY TYPE
Large Metro	4,619	4,231	469	302	202^a	99
Small Metro	3,145	2,702	349	245	155	100
250K - 1 Mil. Pop.	2,095	1,863	249	136	135	67
< 250K Pop.	1,050	840	99	109	20	33
Nonmetro	1,444	1,280	67	79	21	30
Urbanized	671	535	39	45	14	19
Less Urbanized	709	654	26	26	7	3
Completely Rural	64	91	1	7	*	7

120404

Table 1.74B – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	3.6^a	3.2	0.3^a	0.2	0.1^a	0.1
GEOGRAPHIC DIVISION
Northeast	3.5	3.0	0.5	0.3	0.2	0.1
New England	4.3	2.9	0.7	0.4	0.5	0.2
Middle Atlantic	3.3	3.0	0.4	0.3	0.1	0.1
Midwest	3.2	3.0	0.3	0.3	0.1	0.1
East North Central	2.9	3.2	0.4	0.4	0.2	0.2
West North Central	3.8^a	2.7	0.1	0.2	0.1	0.1
South	3.6	3.0	0.4	0.3	0.2	0.1
South Atlantic	4.0	3.1	0.3	0.3	0.1	0.1
East South Central	3.6	3.1	0.5	0.4	0.3	0.1
West South Central	2.8	2.8	0.4	0.2	0.2	0.1
West	4.2	3.8	0.2	0.1	0.1	0.0
Mountain	4.7	3.8	0.3	0.1	0.0	0.0
Pacific	4.0	3.8	0.2	0.1	0.1	0.0
COUNTY TYPE
Large Metro	3.4	3.1	0.3^a	0.2	0.1^a	0.1
Small Metro	4.1^a	3.4	0.4	0.3	0.2	0.1
250K - 1 Mil. Pop.	4.1	3.4	0.5^a	0.2	0.3	0.1
< 250K Pop.	4.0	3.2	0.4	0.4	0.1	0.1
Nonmetro	3.6	3.2	0.2	0.2	0.1	0.1
Urbanized	3.9	3.2	0.2	0.3	0.1	0.1
Less Urbanized	3.6	3.4	0.1	0.1	0.0	0.0
Completely Rural	1.7	2.2	0.0	0.2	*	0.2

120404

Table 1.75A – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	37,544	36,362	4,543^a	4,069	1,207^a	972
GEOGRAPHIC DIVISION
Northeast	6,896	6,610	880	722	163	173
New England	2,113	2,072	256	236	46	74
Middle Atlantic	4,784	4,538	624	486	116	99
Midwest	7,136	7,381	801	751	214	162
East North Central	4,981	5,224	556	530	149	104
West North Central	2,155	2,157	245	221	65	58
South	11,862	11,592	1,182	1,184	313	292
South Atlantic	6,599	6,145	611	665	197	124
East South Central	1,594	1,754	151	128	26	55
West South Central	3,669	3,693	420	390	90	113
West	11,649	10,779	1,680	1,412	517^a	346
Mountain	3,631	3,346	502	374	144	113
Pacific	8,019	7,433	1,178	1,038	373^a	233
COUNTY TYPE
Large Metro	20,777	19,624	2,675	2,356	653	575
Small Metro	11,634	11,815	1,385	1,307	424^a	298
250K - 1 Mil. Pop.	7,763	8,269	916	916	264	207
< 250K Pop.	3,871	3,546	469	390	160^a	91
Nonmetro	5,133	4,923	483	406	130	99
Urbanized	2,459	2,250	267	221	89	51
Less Urbanized	2,345	2,189	196	164	40	42
Completely Rural	329	484	21	21	1	6

120404

Table 1.75B – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	14.8^a	14.1	1.8^a	1.6	0.5^a	0.4
GEOGRAPHIC DIVISION
Northeast	14.8	14.1	1.9	1.5	0.3	0.4
New England	17.2	16.8	2.1	1.9	0.4	0.6
Middle Atlantic	14.0	13.1	1.8	1.4	0.3	0.3
Midwest	12.9	13.3	1.4	1.3	0.4	0.3
East North Central	12.9	13.5	1.4	1.4	0.4	0.3
West North Central	12.8	12.7	1.5	1.3	0.4	0.3
South	12.8	12.2	1.3	1.2	0.3	0.3
South Atlantic	13.5	12.2	1.2	1.3	0.4	0.2
East South Central	10.6	11.5	1.0	0.8	0.2	0.4
West South Central	12.7	12.4	1.5	1.3	0.3	0.4
West	19.8^a	18.0	2.9	2.4	0.9^a	0.6
Mountain	20.1	18.4	2.8	2.1	0.8	0.6
Pacific	19.7	17.8	2.9	2.5	0.9^a	0.6
COUNTY TYPE
Large Metro	15.3	14.3	2.0	1.7	0.5	0.4
Small Metro	15.0	14.7	1.8	1.6	0.5^a	0.4
250K - 1 Mil. Pop.	15.1	15.2	1.8	1.7	0.5	0.4
< 250K Pop.	14.9	13.6	1.8	1.5	0.6^a	0.3
Nonmetro	12.7	12.3	1.2	1.0	0.3	0.2
Urbanized	14.4	13.4	1.6	1.3	0.5	0.3
Less Urbanized	11.9	11.4	1.0	0.9	0.2	0.2
Completely Rural	8.8	11.5	0.6	0.5	0.0	0.1

120404

Table 1.76A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	21,778	20,523	2,048	1,861	690	624
GEOGRAPHIC DIVISION
Northeast	4,088	4,323	451	351	147	110
New England	1,121	1,174	104	104	36	33
Middle Atlantic	2,968	3,149	347	247	111	77
Midwest	4,425	4,181	397	351	117	116
East North Central	3,243	3,034	289^a	208	101^a	52
West North Central	1,182	1,147	108	143	17	64
South	7,025	6,411	667	533	284	208
South Atlantic	3,934	3,356	379	294	207	121
East South Central	1,010	1,039	111	71	30	27
West South Central	2,082	2,016	177	168	47	60
West	6,239	5,608	533	626	141	190
Mountain	1,931	1,710	144	212	56	54
Pacific	4,308	3,898	389	415	85	135
COUNTY TYPE
Large Metro	12,091	11,277	1,199	974	439	290
Small Metro	6,882	6,706	589	683	194	270
250K - 1 Mil. Pop.	4,725	4,805	396	495	138	212
< 250K Pop.	2,157	1,901	192	188	56	58
Nonmetro	2,805	2,541	260^a	203	58	64
Urbanized	1,349	1,190	107	100	24	39
Less Urbanized	1,255	1,145	123	89	27	23
Completely Rural	201	206	30	15	7	2

120404

Table 1.76B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	8.6^a	8.0	0.8	0.7	0.3	0.2
GEOGRAPHIC DIVISION
Northeast	8.8	9.2	1.0	0.7	0.3	0.2
New England	9.1	9.5	0.9	0.8	0.3	0.3
Middle Atlantic	8.7	9.1	1.0	0.7	0.3	0.2
Midwest	8.0	7.5	0.7	0.6	0.2	0.2
East North Central	8.4	7.8	0.8^a	0.5	0.3^a	0.1
West North Central	7.0	6.7	0.6	0.8	0.1	0.4
South	7.6	6.7	0.7	0.6	0.3	0.2
South Atlantic	8.0^a	6.7	0.8	0.6	0.4	0.2
East South Central	6.7	6.8	0.7^a	0.5	0.2	0.2
West South Central	7.2	6.8	0.6	0.6	0.2	0.2
West	10.6	9.4	0.9	1.0	0.2	0.3
Mountain	10.7	9.4	0.8	1.2	0.3	0.3
Pacific	10.6	9.4	1.0	1.0	0.2	0.3
COUNTY TYPE
Large Metro	8.9	8.2	0.9	0.7	0.3	0.2
Small Metro	8.9	8.3	0.8	0.8	0.3	0.3
250K - 1 Mil. Pop.	9.2	8.8	0.8	0.9	0.3	0.4
< 250K Pop.	8.3	7.3	0.7	0.7	0.2	0.2
Nonmetro	6.9	6.3	0.6	0.5	0.1	0.2
Urbanized	7.9	7.1	0.6	0.6	0.1	0.2
Less Urbanized	6.4	6.0	0.6	0.5	0.1	0.1
Completely Rural	5.4	4.9	0.8	0.3	0.2	0.0

120404

Table 1.77A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	2,015	1,877	885	820	262	223
GEOGRAPHIC DIVISION
Northeast	344	303	156	151	44	38
New England	100^a	73	46	38	18	8
Middle Atlantic	244	230	110	113	27	29
Midwest	447	406	191	162	58	42
East North Central	320^a	267	134^a	100	49^a	26
West North Central	127	139	56	63	9	16
South	657	632	305	251	102	77
South Atlantic	339	296	152	112	48	33
East South Central	139^a	102	76^a	45	23	19
West South Central	179^a	234	77	94	32	25
West	567	536	234	256	58	66
Mountain	178	148	65	71	14	11
Pacific	389	388	169	184	44	55
COUNTY TYPE
Large Metro	1,070	1,000	465	442	142	98
Small Metro	650	568	263	253	87	85
250K - 1 Mil. Pop.	464	398	179	196	56	68
< 250K Pop.	186	170	84	57	31	17
Nonmetro	295	310	157	125	33	39
Urbanized	113	120	63	57	10	18
Less Urbanized	151	161	76	59	18	19
Completely Rural	30	28	19	8	5	2

120404

Table 1.77B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	8.3^a	7.5	3.6	3.3	1.1	0.9
GEOGRAPHIC DIVISION
Northeast	8.1	7.1	3.7	3.5	1.0	0.9
New England	9.1^a	6.6	4.2	3.4	1.6	0.7
Middle Atlantic	7.8	7.3	3.5	3.6	0.9	0.9
Midwest	8.4	7.5	3.6	3.0	1.1	0.8
East North Central	8.6^a	7.0	3.6^a	2.6	1.3^a	0.7
West North Central	8.0	8.5	3.5	3.8	0.6	1.0
South	7.3	6.8	3.4^a	2.7	1.1	0.8
South Atlantic	7.5	6.4	3.4	2.4	1.1	0.7
East South Central	9.6^a	6.9	5.3^a	3.1	1.6	1.3
West South Central	5.9	7.4	2.6	3.0	1.0	0.8
West	9.7	8.9	4.0	4.3	1.0	1.1
Mountain	10.0	8.0	3.6	3.9	0.8	0.6
Pacific	9.6	9.3	4.2	4.4	1.1	1.3
COUNTY TYPE
Large Metro	8.2	7.5	3.6	3.3	1.1	0.7
Small Metro	8.6^a	7.2	3.5	3.2	1.2	1.1
250K - 1 Mil. Pop.	9.2^b	7.4	3.5	3.6	1.1	1.3
< 250K Pop.	7.5	6.9	3.4	2.3	1.2	0.7
Nonmetro	7.8	8.1	4.2	3.3	0.9	1.0
Urbanized	7.4	7.1	4.1	3.4	0.6	1.1
Less Urbanized	7.8	9.1	3.9	3.3	1.0	1.1
Completely Rural	9.5	8.0	5.9^a	2.4	1.5	0.4

120404

Table 1.78A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	51,832	51,243	16,051^a	14,657	6,957^a	6,119
GEOGRAPHIC DIVISION
Northeast	8,572	8,532	2,697	2,466	1,298	1,048
New England	2,346	2,350	758	691	411	278
Middle Atlantic	6,227	6,182	1,938	1,775	887	770
Midwest	10,678	10,685	3,268	3,144	1,383	1,393
East North Central	7,674	7,529	2,423	2,272	1,080	1,039
West North Central	3,004	3,156	845	871	303	354
South	18,348	18,419	5,602	5,334	2,524	2,145
South Atlantic	9,698	9,515	2,951	2,652	1,378^a	975
East South Central	3,241	3,095	874	927	404	422
West South Central	5,410	5,810	1,777	1,754	742	749
West	14,234	13,606	4,484^a	3,713	1,751	1,534
Mountain	4,523	4,405	1,460	1,239	603	469
Pacific	9,710	9,202	3,024	2,473	1,149	1,065
COUNTY TYPE
Large Metro	28,305	27,040	8,711^a	7,672	3,671^a	3,036
Small Metro	16,190	16,833	5,100	4,844	2,214	2,122
250K - 1 Mil. Pop.	10,740	11,692	3,480	3,207	1,517	1,398
< 250K Pop.	5,450	5,142	1,620	1,637	697	724
Nonmetro	7,337	7,369	2,239	2,141	1,072	961
Urbanized	3,415	3,398	1,061	1,101	533	485
Less Urbanized	3,409	3,196	1,061	873	498	405
Completely Rural	513^a	775	117	168	41	72

120404

Table 1.78B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	20.4	19.9	6.3^b	5.7	2.7^b	2.4
GEOGRAPHIC DIVISION
Northeast	18.4	18.2	5.8	5.3	2.8	2.2
New England	19.2	19.1	6.2	5.6	3.4^a	2.3
Middle Atlantic	18.2	17.9	5.7	5.1	2.6	2.2
Midwest	19.3	19.2	5.9	5.6	2.5	2.5
East North Central	19.9	19.5	6.3	5.9	2.8	2.7
West North Central	17.9	18.6	5.0	5.1	1.8	2.1
South	19.7	19.4	6.0	5.6	2.7^a	2.3
South Atlantic	19.8	19.0	6.0	5.3	2.8^b	1.9
East South Central	21.5	20.2	5.8	6.1	2.7	2.8
West South Central	18.7	19.6	6.2	5.9	2.6	2.5
West	24.2	22.7	7.6^b	6.2	3.0	2.6
Mountain	25.1	24.3	8.1	6.8	3.3	2.6
Pacific	23.8	22.1	7.4^a	5.9	2.8	2.6
COUNTY TYPE
Large Metro	20.9	19.8	6.4^a	5.6	2.7^a	2.2
Small Metro	20.9	20.9	6.6	6.0	2.9	2.6
250K - 1 Mil. Pop.	20.9	21.5	6.8^a	5.9	2.9	2.6
< 250K Pop.	21.0	19.7	6.2	6.3	2.7	2.8
Nonmetro	18.1	18.3	5.5	5.3	2.6	2.4
Urbanized	20.0	20.2	6.2	6.6	3.1	2.9
Less Urbanized	17.3	16.7	5.4	4.6	2.5	2.1
Completely Rural	13.8	18.5	3.1	4.0	1.1	1.7

120404

Table 1.79A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	2,591	2,522	1,812	1,749	721	688
GEOGRAPHIC DIVISION
Northeast	336	375	247	264	94	99
New England	88	89	65	60	23	21
Middle Atlantic	248	286	182	204	71	78
Midwest	564	539	414	384	159	167
East North Central	390	368	286	268	114	119
West North Central	174	172	128	116	45	48
South	975	941	651	652	266	269
South Atlantic	488^a	401	326	278	120	112
East South Central	161	173	103	119	48	58
West South Central	326	367	222	255	98	99
West	715	667	500	449	202	153
Mountain	252	209	189^a	139	86	53
Pacific	463	458	311	310	116	100
COUNTY TYPE
Large Metro	1,313	1,284	928	886	360	315
Small Metro	853	803	594	577	248	255
250K - 1 Mil. Pop.	577	546	405	396	166	171
< 250K Pop.	276	257	189	181	82	84
Nonmetro	425	435	291	286	113	118
Urbanized	179	184	133	123	53	53
Less Urbanized	219	214	143	137	51	54
Completely Rural	27	38	16	26	9	11

120404

Table 1.79B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	10.6	10.1	7.4	7.0	3.0	2.8
GEOGRAPHIC DIVISION
Northeast	7.9	8.8	5.8	6.2	2.2	2.3
New England	8.1	8.0	6.0	5.4	2.1	1.9
Middle Atlantic	7.9	9.0	5.8	6.4	2.3	2.4
Midwest	10.6	9.9	7.8	7.0	3.0	3.1
East North Central	10.4	9.7	7.6	7.0	3.0	3.1
West North Central	11.0	10.5	8.0	7.1	2.8	3.0
South	10.9	10.2	7.3	7.0	3.0	2.9
South Atlantic	10.9^a	8.7	7.3	6.0	2.7	2.4
East South Central	11.1	11.7	7.1	8.0	3.3	3.9
West South Central	10.8	11.6	7.4	8.1	3.2	3.1
West	12.3	11.1	8.6	7.5	3.5	2.6
Mountain	14.1	11.3	10.6^a	7.5	4.8	2.9
Pacific	11.5	11.0	7.7	7.5	2.9	2.4
COUNTY TYPE
Large Metro	10.1	9.6	7.1	6.7	2.8	2.4
Small Metro	11.3	10.2	7.9	7.4	3.3	3.3
250K - 1 Mil. Pop.	11.5	10.2	8.0	7.4	3.3	3.2
< 250K Pop.	11.1	10.4	7.6	7.3	3.3	3.4
Nonmetro	11.2	11.4	7.7	7.5	3.0	3.1
Urbanized	11.7	10.9	8.7	7.3	3.5	3.1
Less Urbanized	11.3	12.1	7.4	7.7	2.6	3.0
Completely Rural	8.4	10.6	5.0	7.4	2.9	3.2

120404

Table 1.80A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	9,832^a	9,373	4,876^b	4,366	1,997^b	1,711
GEOGRAPHIC DIVISION
Northeast	1,666^b	1,452	893^a	752	351	285
New England	517^a	435	263	227	116	89
Middle Atlantic	1,149	1,017	629^a	525	235	196
Midwest	2,107	2,031	1,107^a	987	472	401
East North Central	1,470	1,411	781	695	349	292
West North Central	637	619	326	293	123	109
South	3,664	3,465	1,763^a	1,554	712	614
South Atlantic	1,802	1,731	880	761	345	290
East South Central	605	608	277	287	126	131
West South Central	1,257	1,126	607	506	241	192
West	2,395	2,425	1,113	1,072	462	411
Mountain	749	818	347	390	154	129
Pacific	1,646	1,607	766	682	309	283
COUNTY TYPE
Large Metro	5,049	4,754	2,520^a	2,221	983	886
Small Metro	3,411	3,273	1,703	1,526	736^a	598
250K - 1 Mil. Pop.	2,193	2,112	1,082	975	486^b	352
< 250K Pop.	1,218	1,161	621	551	250	247
Nonmetro	1,372	1,346	652	619	277	227
Urbanized	670	698	322	324	140	111
Less Urbanized	606	546	288	258	130	104
Completely Rural	96	102	43	37	8	12

120404

Table 1.80B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	28.9^b	27.3	14.3^b	12.7	5.9^b	5.0
GEOGRAPHIC DIVISION
Northeast	27.6^b	23.7	14.8^b	12.3	5.8	4.7
New England	31.8^a	27.1	16.2	14.2	7.1	5.5
Middle Atlantic	26.0^a	22.5	14.2^a	11.6	5.3	4.3
Midwest	28.1	27.7	14.8	13.5	6.3	5.5
East North Central	28.6	27.9	15.2	13.7	6.8	5.8
West North Central	27.0	27.2	13.8	12.9	5.2	4.8
South	29.5^a	27.5	14.2^a	12.3	5.7	4.9
South Atlantic	28.5	26.9	13.9	11.8	5.5	4.5
East South Central	30.4	30.3	13.9	14.3	6.4	6.5
West South Central	30.6^a	27.1	14.7^a	12.2	5.9	4.6
West	29.5	29.5	13.7	13.0	5.7	5.0
Mountain	30.0	33.1	13.9	15.8	6.1	5.2
Pacific	29.3	27.9	13.6	11.8	5.5	4.9
COUNTY TYPE
Large Metro	27.8^a	25.8	13.9^b	12.1	5.4	4.8
Small Metro	30.7	29.4	15.3^a	13.7	6.6^a	5.4
250K - 1 Mil. Pop.	31.2	29.8	15.4	13.8	6.9^b	5.0
< 250K Pop.	29.7	28.6	15.2	13.6	6.1	6.1
Nonmetro	28.6	28.4	13.6	13.0	5.8	4.8
Urbanized	31.7	31.6	15.2	14.7	6.6	5.0
Less Urbanized	26.0	26.1	12.4	12.3	5.6	5.0
Completely Rural	27.6	23.0	12.2	8.3	2.2	2.6

120404

Table 1.81A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	39,409	39,348	9,362	8,542	4,239	3,720
GEOGRAPHIC DIVISION
Northeast	6,570	6,704	1,557	1,450	853	664
New England	1,741	1,826	430	403	272	168
Middle Atlantic	4,829	4,878	1,128	1,047	581	496
Midwest	8,007	8,115	1,746	1,772	753	825
East North Central	5,815	5,750	1,356	1,309	618	629
West North Central	2,192	2,365	391	463	135	196
South	13,708	14,014	3,188	3,128	1,546	1,262
South Atlantic	7,407	7,384	1,746	1,613	913^a	573
East South Central	2,475	2,313	494	522	230	233
West South Central	3,826	4,317	948	993	403	457
West	11,124	10,514	2,871^a	2,192	1,087	969
Mountain	3,522	3,378	924	711	363	287
Pacific	7,602	7,136	1,947	1,481	724	682
COUNTY TYPE
Large Metro	21,943	21,002	5,263	4,565	2,328	1,835
Small Metro	11,926	12,758	2,804	2,741	1,230	1,268
250K - 1 Mil. Pop.	7,970^a	9,034	1,993	1,836	865	875
< 250K Pop.	3,956	3,724	810	905	365	393
Nonmetro	5,540	5,588	1,296	1,236	681	616
Urbanized	2,566	2,516	607	654	340	321
Less Urbanized	2,584	2,436	630	478	317	247
Completely Rural	390^a	635	59	105	24	49

120404

Table 1.81B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	20.2	19.8	4.8	4.3	2.2	1.9
GEOGRAPHIC DIVISION
Northeast	18.1	18.4	4.3	4.0	2.4	1.8
New England	18.3	19.0	4.5	4.2	2.9	1.7
Middle Atlantic	18.1	18.1	4.2	3.9	2.2	1.8
Midwest	18.8	18.9	4.1	4.1	1.8	1.9
East North Central	19.6	19.3	4.6	4.4	2.1	2.1
West North Central	17.0	18.1	3.0	3.5	1.0	1.5
South	19.1	19.1	4.5	4.3	2.2	1.7
South Atlantic	19.4	18.9	4.6	4.1	2.4^a	1.5
East South Central	21.2	19.6	4.2	4.4	2.0	2.0
West South Central	17.6	19.3	4.4	4.4	1.9	2.0
West	24.8	23.1	6.4^a	4.8	2.4	2.1
Mountain	25.6	24.4	6.7	5.1	2.6	2.1
Pacific	24.4	22.5	6.3	4.7	2.3	2.1
COUNTY TYPE
Large Metro	21.0	20.0	5.0	4.3	2.2^a	1.7
Small Metro	20.3	20.7	4.8	4.4	2.1	2.1
250K - 1 Mil. Pop.	20.2	21.5	5.1	4.4	2.2	2.1
< 250K Pop.	20.4	19.0	4.2	4.6	1.9	2.0
Nonmetro	17.4	17.7	4.1	3.9	2.1	1.9
Urbanized	19.1	19.5	4.5	5.1	2.5	2.5
Less Urbanized	16.8	15.9	4.1	3.1	2.1	1.6
Completely Rural	12.7^a	18.7	1.9	3.1	0.8	1.4

120404

Table 1.82A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	49,241	48,721	14,238^a	12,908	6,236^a	5,431
GEOGRAPHIC DIVISION
Northeast	8,236	8,157	2,450	2,202	1,204	949
New England	2,258	2,261	693	631	388	257
Middle Atlantic	5,978	5,896	1,757	1,571	816	692
Midwest	10,114	10,146	2,853	2,760	1,224	1,226
East North Central	7,284	7,161	2,137	2,004	967	921
West North Central	2,829	2,985	717	756	258	305
South	17,373	17,479	4,951	4,682	2,258	1,876
South Atlantic	9,209	9,114	2,625	2,374	1,258^a	863
East South Central	3,080	2,921	771	809	356	364
West South Central	5,084	5,443	1,555	1,499	644	649
West	13,519	12,939	3,984^a	3,264	1,550	1,380
Mountain	4,271	4,196	1,271	1,101	517	415
Pacific	9,248	8,743	2,713	2,163	1,033	965
COUNTY TYPE
Large Metro	26,992	25,756	7,784^a	6,786	3,311^a	2,721
Small Metro	15,337	16,031	4,507	4,267	1,966	1,866
250K - 1 Mil. Pop.	10,164	11,146	3,075	2,811	1,351	1,227
< 250K Pop.	5,174	4,885	1,432	1,456	615	640
Nonmetro	6,912	6,934	1,948	1,855	958	843
Urbanized	3,236	3,214	928	978	480	432
Less Urbanized	3,190	2,982	918	736	447	351
Completely Rural	486^a	737	102	142	32	60

120404

Table 1.82B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	21.5	20.9	6.2^b	5.5	2.7^a	2.3
GEOGRAPHIC DIVISION
Northeast	19.5	19.1	5.8	5.2	2.8	2.2
New England	20.2	20.2	6.2	5.6	3.5	2.3
Middle Atlantic	19.2	18.8	5.6	5.0	2.6	2.2
Midwest	20.2	20.2	5.7	5.5	2.4	2.4
East North Central	20.9	20.5	6.1	5.7	2.8	2.6
West North Central	18.6	19.4	4.7	4.9	1.7	2.0
South	20.7	20.3	5.9	5.4	2.7^a	2.2
South Atlantic	20.7	20.0	5.9	5.2	2.8^b	1.9
East South Central	22.6	21.1	5.7	5.8	2.6	2.6
West South Central	19.7	20.5	6.0	5.6	2.5	2.4
West	25.5	24.0	7.5^a	6.1	2.9	2.6
Mountain	26.3	25.7	7.8	6.7	3.2	2.5
Pacific	25.2	23.3	7.4^a	5.8	2.8	2.6
COUNTY TYPE
Large Metro	22.0	20.9	6.3^a	5.5	2.7^a	2.2
Small Metro	21.9	22.0	6.4	5.9	2.8	2.6
250K - 1 Mil. Pop.	21.9	22.7	6.6	5.7	2.9	2.5
< 250K Pop.	22.0	20.7	6.1	6.2	2.6	2.7
Nonmetro	18.8	19.1	5.3	5.1	2.6	2.3
Urbanized	20.8	21.3	6.0	6.5	3.1	2.9
Less Urbanized	18.0	17.1	5.2	4.2	2.5	2.0
Completely Rural	14.3	19.2	3.0	3.7	0.9	1.6

120404

Table 1.83A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	34,908	34,247	12,242^a	11,143	5,093^a	4,471
GEOGRAPHIC DIVISION
Northeast	5,656	5,415	1,987	1,858	904	757
New England	1,702	1,560	559	491	301	220
Middle Atlantic	3,954	3,855	1,428	1,367	604	537
Midwest	7,257	7,375	2,601	2,498	1,101	1,086
East North Central	5,391	5,348	1,912	1,857	860	868
West North Central	1,866	2,026	689	641	241	218
South	12,357	12,528	4,092	3,992	1,759	1,512
South Atlantic	6,231	6,227	2,088	1,916	889^a	621
East South Central	2,334	2,124	676	708	318	327
West South Central	3,792	4,177	1,327	1,368	552	563
West	9,639	8,929	3,562^b	2,795	1,328	1,116
Mountain	3,235	2,881	1,183	954	432	332
Pacific	6,404	6,049	2,380^a	1,842	896	784
COUNTY TYPE
Large Metro	18,773	17,755	6,565^a	5,715	2,600^a	2,140
Small Metro	11,082	11,417	3,885	3,862	1,623	1,621
250K - 1 Mil. Pop.	7,263	7,817	2,609	2,571	1,135	1,081
< 250K Pop.	3,819	3,600	1,276	1,291	488	540
Nonmetro	5,054	5,075	1,792	1,566	870	710
Urbanized	2,376	2,397	825	792	418	348
Less Urbanized	2,325	2,215	862^a	652	413	297
Completely Rural	353	463	106	123	39	64

120404

Table 1.83B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	13.8	13.3	4.8^b	4.3	2.0^a	1.7
GEOGRAPHIC DIVISION
Northeast	12.2	11.5	4.3	4.0	1.9	1.6
New England	13.9	12.7	4.6	4.0	2.5	1.8
Middle Atlantic	11.5	11.2	4.2	4.0	1.8	1.6
Midwest	13.1	13.2	4.7	4.5	2.0	1.9
East North Central	14.0	13.8	5.0	4.8	2.2	2.2
West North Central	11.1	11.9	4.1	3.8	1.4	1.3
South	13.3	13.2	4.4	4.2	1.9	1.6
South Atlantic	12.7	12.4	4.3	3.8	1.8^a	1.2
East South Central	15.5	13.9	4.5	4.6	2.1	2.1
West South Central	13.1	14.1	4.6	4.6	1.9	1.9
West	16.4	14.9	6.1^b	4.7	2.3	1.9
Mountain	17.9	15.9	6.6	5.3	2.4	1.8
Pacific	15.7	14.5	5.8^a	4.4	2.2	1.9
COUNTY TYPE
Large Metro	13.8	13.0	4.8^a	4.2	1.9^a	1.6
Small Metro	14.3	14.2	5.0	4.8	2.1	2.0
250K - 1 Mil. Pop.	14.1	14.3	5.1	4.7	2.2	2.0
< 250K Pop.	14.7	13.8	4.9	4.9	1.9	2.1
Nonmetro	12.5	12.6	4.4	3.9	2.1	1.8
Urbanized	13.9	14.3	4.8	4.7	2.4	2.1
Less Urbanized	11.8	11.5	4.4^a	3.4	2.1	1.6
Completely Rural	9.5	11.0	2.8	2.9	1.0	1.5

120404

Table 1.84A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	2,245	2,150	1,522	1,484	607	563
GEOGRAPHIC DIVISION
Northeast	290	326	216	229	86	86
New England	72	74	55	51	21	19
Middle Atlantic	217	252	161	178	65	66
Midwest	493	463	344	326	130	141
East North Central	341	318	237	231	96	98
West North Central	153	144	107	95	34	44
South	840	768	540	534	219	203
South Atlantic	412^a	316	266	222	94	80
East South Central	144	145	89	107	41	48
West South Central	284	307	184	205	84	75
West	621	593	422	395	172	133
Mountain	218	187	157	123	73	45
Pacific	403	406	265	271	99	89
COUNTY TYPE
Large Metro	1,103	1,087	753	752	296	252
Small Metro	762	694	515	494	214	209
250K - 1 Mil. Pop.	515	479	359	348	150	139
< 250K Pop.	246	215	156	146	64	69
Nonmetro	379	369	253	238	97	102
Urbanized	163	158	122	100	48	47
Less Urbanized	192	180	117	115	42	46
Completely Rural	25	31	14	23	8	8

120404

Table 1.84B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	9.2	8.6	6.3	5.9	2.5	2.3
GEOGRAPHIC DIVISION
Northeast	6.8	7.6	5.1	5.4	2.0	2.0
New England	6.6	6.7	5.1	4.6	2.0	1.7
Middle Atlantic	6.9	8.0	5.1	5.6	2.1	2.1
Midwest	9.2	8.5	6.4	6.0	2.4	2.6
East North Central	9.1	8.4	6.3	6.1	2.6	2.6
West North Central	9.6	8.8	6.7	5.8	2.1	2.7
South	9.4	8.3	6.0	5.8	2.4	2.2
South Atlantic	9.2^b	6.8	5.9	4.8	2.1	1.7
East South Central	10.0	9.8	6.2	7.2	2.9	3.3
West South Central	9.4	9.7	6.1	6.5	2.8	2.4
West	10.7	9.9	7.2	6.6	3.0	2.2
Mountain	12.2	10.2	8.8	6.7	4.1^a	2.4
Pacific	10.0	9.8	6.6	6.5	2.4	2.1
COUNTY TYPE
Large Metro	8.5	8.2	5.8	5.6	2.3	1.9
Small Metro	10.1^a	8.9	6.9	6.3	2.8	2.7
250K - 1 Mil. Pop.	10.2	8.9	7.1	6.5	3.0	2.6
< 250K Pop.	9.9	8.7	6.3	5.9	2.6	2.8
Nonmetro	10.0	9.6	6.7	6.2	2.6	2.7
Urbanized	10.7	9.3	8.0	5.9	3.1	2.8
Less Urbanized	9.9	10.1	6.0	6.5	2.2	2.6
Completely Rural	7.9	8.7	4.5	6.5	2.5	2.3

120404

Table 1.85A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	8,143^b	7,600	3,779^b	3,353	1,510^b	1,220
GEOGRAPHIC DIVISION
Northeast	1,369^b	1,149	662^a	547	255	194
New England	411	363	182	164	79	60
Middle Atlantic	958^b	786	481^a	382	176	134
Midwest	1,765	1,712	905^b	758	388^a	305
East North Central	1,244	1,200	641^a	544	285	230
West North Central	521	512	264	214	103	74
South	2,958	2,739	1,316	1,167	506^a	405
South Atlantic	1,419	1,322	623	552	232^a	163
East South Central	512	518	226	233	87	113
West South Central	1,028^a	899	466	383	187^a	129
West	2,050	2,000	896	881	362	316
Mountain	636	670	278	315	113	92
Pacific	1,414	1,330	618	566	249	224
COUNTY TYPE
Large Metro	4,140^a	3,791	1,913	1,703	730	623
Small Metro	2,840	2,681	1,351^a	1,172	570^b	419
250K - 1 Mil. Pop.	1,830	1,727	854	749	382^b	242
< 250K Pop.	1,010	953	496	423	188	177
Nonmetro	1,163	1,128	515	478	210	178
Urbanized	578	590	254	242	110	82
Less Urbanized	501	458	221	208	93	86
Completely Rural	85	81	40	28	7	11

120404

Table 1.85B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	23.9^b	22.2	11.1^b	9.8	4.4^b	3.6
GEOGRAPHIC DIVISION
Northeast	22.6^b	18.8	11.0^a	8.9	4.2	3.2
New England	25.3	22.6	11.2	10.2	4.8	3.7
Middle Atlantic	21.7^b	17.4	10.9^a	8.5	4.0	3.0
Midwest	23.5	23.3	12.1^a	10.3	5.2^a	4.1
East North Central	24.2	23.7	12.5^a	10.7	5.5	4.5
West North Central	22.1	22.5	11.2	9.4	4.4	3.3
South	23.8^a	21.7	10.6^a	9.3	4.1^a	3.2
South Atlantic	22.5	20.5	9.9	8.6	3.7^a	2.5
East South Central	25.7	25.8	11.4	11.6	4.4	5.6
West South Central	25.0^a	21.6	11.3^a	9.2	4.5^a	3.1
West	25.3	24.3	11.0	10.7	4.5	3.8
Mountain	25.5	27.1	11.1	12.8	4.5	3.7
Pacific	25.2	23.1	11.0	9.8	4.4	3.9
COUNTY TYPE
Large Metro	22.8^b	20.6	10.5^a	9.3	4.0	3.4
Small Metro	25.5	24.0	12.1^a	10.5	5.1^b	3.8
250K - 1 Mil. Pop.	26.0	24.4	12.2	10.6	5.4^b	3.4
< 250K Pop.	24.7	23.5	12.1	10.4	4.6	4.4
Nonmetro	24.3	23.8	10.8	10.1	4.4	3.8
Urbanized	27.4	26.7	12.0	11.0	5.2	3.7
Less Urbanized	21.5	21.9	9.5	9.9	4.0	4.1
Completely Rural	24.2	18.3	11.5	6.4	2.0	2.4

120404

Table 1.86A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	24,521	24,497	6,941	6,306	2,975	2,688
GEOGRAPHIC DIVISION
Northeast	3,997	3,940	1,108	1,082	563	477
New England	1,218	1,122	322	275	201	141
Middle Atlantic	2,779	2,817	786	806	363	337
Midwest	4,998	5,200	1,352	1,414	583	640
East North Central	3,806	3,830	1,033	1,082	479	540
West North Central	1,192	1,370	319	332	104	100
South	8,558	9,021	2,236	2,291	1,034	903
South Atlantic	4,401	4,589	1,199	1,141	564	378
East South Central	1,678	1,461	361	369	190	166
West South Central	2,480	2,970	677	781	281	359
West	6,968	6,336	2,244^b	1,520	794	667
Mountain	2,381	2,023	747^a	515	246	196
Pacific	4,587	4,313	1,497^a	1,005	549	471
COUNTY TYPE
Large Metro	13,529	12,877	3,898	3,261	1,574	1,265
Small Metro	7,480	8,042	2,019	2,195	838	994
250K - 1 Mil. Pop.	4,918	5,611	1,396	1,473	603	700
< 250K Pop.	2,562	2,431	623	722	236	294
Nonmetro	3,512	3,578	1,024	850	562	430
Urbanized	1,635	1,649	449	450	261	219
Less Urbanized	1,633	1,578	524^a	329	277	166
Completely Rural	243	351	51	71	24	46

120404

Table 1.86B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	12.6	12.4	3.6	3.2	1.5	1.4
GEOGRAPHIC DIVISION
Northeast	11.0	10.8	3.1	3.0	1.6	1.3
New England	12.8	11.7	3.4	2.9	2.1	1.5
Middle Atlantic	10.4	10.5	2.9	3.0	1.4	1.3
Midwest	11.8	12.1	3.2	3.3	1.4	1.5
East North Central	12.8	12.8	3.5	3.6	1.6	1.8
West North Central	9.3	10.5	2.5	2.5	0.8	0.8
South	12.0	12.3	3.1	3.1	1.4	1.2
South Atlantic	11.5	11.7	3.1	2.9	1.5	1.0
East South Central	14.4	12.4	3.1	3.1	1.6	1.4
West South Central	11.4	13.3	3.1	3.5	1.3	1.6
West	15.5	13.9	5.0^b	3.3	1.8	1.5
Mountain	17.3	14.6	5.4^a	3.7	1.8	1.4
Pacific	14.8	13.6	4.8^a	3.2	1.8	1.5
COUNTY TYPE
Large Metro	12.9	12.3	3.7	3.1	1.5	1.2
Small Metro	12.7	13.1	3.4	3.6	1.4	1.6
250K - 1 Mil. Pop.	12.5	13.3	3.5	3.5	1.5	1.7
< 250K Pop.	13.2	12.4	3.2	3.7	1.2	1.5
Nonmetro	11.0	11.3	3.2	2.7	1.8	1.4
Urbanized	12.2	12.8	3.3	3.5	1.9	1.7
Less Urbanized	10.6	10.3	3.4^a	2.1	1.8	1.1
Completely Rural	8.0	10.3	1.7	2.1	0.8	1.3

120404

Table 1.87A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	32,664	32,097	10,720^a	9,659	4,485^a	3,908
GEOGRAPHIC DIVISION
Northeast	5,366	5,089	1,771	1,628	818	672
New England	1,630	1,485	504	440	279	201
Middle Atlantic	3,736	3,603	1,267	1,188	539	471
Midwest	6,763	6,912	2,257	2,172	971	945
East North Central	5,051	5,030	1,674	1,626	764	770
West North Central	1,713	1,882	582	545	207	174
South	11,516	11,759	3,552	3,458	1,540	1,309
South Atlantic	5,820	5,911	1,822	1,693	795^a	541
East South Central	2,190	1,979	587	602	277	279
West South Central	3,507	3,869	1,143	1,163	468	489
West	9,018	8,336	3,140^b	2,401	1,156	983
Mountain	3,017	2,693	1,025	830	358	287
Pacific	6,001	5,643	2,115^a	1,570	798	695
COUNTY TYPE
Large Metro	17,669	16,668	5,811^a	4,964	2,304	1,888
Small Metro	10,320	10,722	3,369	3,367	1,408	1,412
250K - 1 Mil. Pop.	6,748	7,338	2,250	2,223	985	941
< 250K Pop.	3,572	3,384	1,119	1,145	424	471
Nonmetro	4,674	4,706	1,539	1,328	772	608
Urbanized	2,213	2,239	704	692	371	300
Less Urbanized	2,133	2,035	745^a	537	371	251
Completely Rural	328	432	91	99	31	56

120404

Table 1.87B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2010 and 2011
Geographic Characteristic	Lifetime (2010)	Lifetime (2011)	Past Year (2010)	Past Year (2011)	Past Month (2010)	Past Month (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
TOTAL	14.2	13.8	4.7^b	4.2	2.0^a	1.7
GEOGRAPHIC DIVISION
Northeast	12.7	11.9	4.2	3.8	1.9	1.6
New England	14.6	13.3	4.5	3.9	2.5	1.8
Middle Atlantic	12.0	11.5	4.1	3.8	1.7	1.5
Midwest	13.5	13.8	4.5	4.3	1.9	1.9
East North Central	14.5	14.4	4.8	4.7	2.2	2.2
West North Central	11.3	12.3	3.8	3.6	1.4	1.1
South	13.7	13.7	4.2	4.0	1.8	1.5
South Atlantic	13.1	13.0	4.1	3.7	1.8^a	1.2
East South Central	16.1	14.3	4.3	4.4	2.0	2.0
West South Central	13.6	14.6	4.4	4.4	1.8	1.8
West	17.0	15.5	5.9^b	4.5	2.2	1.8
Mountain	18.6	16.5	6.3	5.1	2.2	1.8
Pacific	16.3	15.0	5.8^a	4.2	2.2	1.9
COUNTY TYPE
Large Metro	14.4	13.5	4.7^a	4.0	1.9^a	1.5
Small Metro	14.8	14.7	4.8	4.6	2.0	1.9
250K - 1 Mil. Pop.	14.5	14.9	4.8	4.5	2.1	1.9
< 250K Pop.	15.2	14.3	4.8	4.8	1.8	2.0
Nonmetro	12.7	12.9	4.2	3.7	2.1	1.7
Urbanized	14.2	14.8	4.5	4.6	2.4	2.0
Less Urbanized	12.0	11.7	4.2^a	3.1	2.1	1.4
Completely Rural	9.6	11.2	2.7	2.6	0.9	1.5

120405

Table 1.88A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Numbers in Thousands, 2010 and 2011
Drug or Method of Administration	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. ² These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview. ³ Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings*. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
HALLUCINOGENS	37,544	36,362	1,000	930	6,295	6,029	30,248	29,403
PCP (Angel Dust, Phencyclidine)	6,255	6,103	76	76	447^a	351	5,731	5,676
LSD (Acid)	23,375	23,000	231	229	2,194	2,054	20,950	20,716
Peyote	5,749	5,257	42	45	336	283	5,370	4,929
Mescaline	8,654	7,840	40	23	386	376	8,228	7,440
Psilocybin (Mushrooms)	21,191	20,881	366	339	3,799^a	3,480	17,026	17,063
Ecstasy (MDMA)	15,929^a	14,570	618	605	4,230	4,222	11,082^b	9,743
INHALANTS	21,778	20,523	2,015	1,877	3,396^a	3,106	16,367	15,540
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush	7,215	7,017	335	304	606	590	6,273	6,124
Correction Fluid, Degreaser, or Cleaning Fluid	1,963	1,841	413	351	331	299	1,219	1,190
Gasoline or Lighter Fluid	3,399	3,295	635	579	502	443	2,261	2,272
Glue, Shoe Polish, or Toluene	4,036^a	3,347	777^a	648	486	401	2,773	2,298
Halothane, Ether, or Other Anesthetics	1,042	980	79	85	196	145	768	750
Lacquer Thinner or Other Paint Solvents	1,836	1,746	290	255	318	247	1,228	1,243
Lighter Gases (Butane, Propane)	841	734	158	170	164	115	518	449
Nitrous Oxide or Whippits	12,297^a	11,263	259	240	2,092	1,893	9,946	9,131
Spray Paints	2,115	2,087	560	634	443	351	1,112	1,102
Other Aerosol Sprays	2,160	2,145	425	397	587	610	1,148	1,138
NEEDLE USE^1,2,3	3,652	3,639	47	48	376	383	3,230	3,208
Heroin Needle Use^1,2	1,766	1,846	24	21	230	224	1,511	1,602
Cocaine Needle Use^1,2	2,278	1,957	*	10	156	135	2,121	1,812
Stimulant Needle Use^1,2,3	1,818	1,619	17	26	130	165	1,670	1,427
Methamphetamine Needle Use^1,2,3	1,561	1,345	11	21	105	107	1,445	1,217
HEROIN	4,144	4,162	46	70	614	594	3,483	3,499
Smoke Heroin²	1,469	1,402	22	36	245	260	1,202	1,106
Sniff or Snort Heroin²	3,082	2,964	17	37	432	400	2,632	2,527

120405

Table 1.88B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Percentages, 2010 and 2011
Drug or Method of Administration	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. ² These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview. ³ Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings*. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
HALLUCINOGENS	14.8^a	14.1	4.1	3.7	18.5	17.6	15.5	14.8
PCP (Angel Dust, Phencyclidine)	2.5	2.4	0.3	0.3	1.3^a	1.0	2.9	2.9
LSD (Acid)	9.2	8.9	0.9	0.9	6.4	6.0	10.7	10.4
Peyote	2.3	2.0	0.2	0.2	1.0	0.8	2.8	2.5
Mescaline	3.4	3.0	0.2	0.1	1.1	1.1	4.2	3.8
Psilocybin (Mushrooms)	8.4	8.1	1.5	1.4	11.1^a	10.1	8.7	8.6
Ecstasy (MDMA)	6.3^b	5.7	2.5	2.4	12.4	12.3	5.7^b	4.9
INHALANTS	8.6^a	8.0	8.3^a	7.5	10.0^a	9.1	8.4	7.8
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush	2.8	2.7	1.4	1.2	1.8	1.7	3.2	3.1
Correction Fluid, Degreaser, or Cleaning Fluid	0.8	0.7	1.7	1.4	1.0	0.9	0.6	0.6
Gasoline or Lighter Fluid	1.3	1.3	2.6	2.3	1.5	1.3	1.2	1.1
Glue, Shoe Polish, or Toluene	1.6^a	1.3	3.2^b	2.6	1.4	1.2	1.4	1.2
Halothane, Ether, or Other Anesthetics	0.4	0.4	0.3	0.3	0.6	0.4	0.4	0.4
Lacquer Thinner or Other Paint Solvents	0.7	0.7	1.2	1.0	0.9	0.7	0.6	0.6
Lighter Gases (Butane, Propane)	0.3	0.3	0.6	0.7	0.5	0.3	0.3	0.2
Nitrous Oxide or Whippits	4.8^a	4.4	1.1	1.0	6.1^a	5.5	5.1	4.6
Spray Paints	0.8	0.8	2.3	2.5	1.3	1.0	0.6	0.6
Other Aerosol Sprays	0.9	0.8	1.7	1.6	1.7	1.8	0.6	0.6
NEEDLE USE^1,2,3	1.4	1.4	0.2	0.2	1.1	1.1	1.7	1.6
Heroin Needle Use^1,2	0.7	0.7	0.1	0.1	0.7	0.7	0.8	0.8
Cocaine Needle Use^1,2	0.9	0.8	*	0.0	0.5	0.4	1.1	0.9
Stimulant Needle Use^1,2,3	0.7	0.6	0.1	0.1	0.4	0.5	0.9	0.7
Methamphetamine Needle Use^1,2,3	0.6	0.5	0.0	0.1	0.3	0.3	0.7	0.6
HEROIN	1.6	1.6	0.2	0.3	1.8	1.7	1.8	1.8
Smoke Heroin²	0.6	0.5	0.1	0.1	0.7	0.8	0.6	0.6
Sniff or Snort Heroin²	1.2	1.2	0.1	0.1	1.3	1.2	1.3	1.3

120405

Table 1.89A – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Numbers in Thousands, 2010 and 2011
Pain Reliever	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	17,904^a	16,507	966	900	3,235^b	2,767	13,703	12,840
Percocet^®, Percodan^®, or Tylox^®	13,786	12,910	415	422	3,178	3,059	10,194	9,429
Vicodin^®, Lortab^®, or Lorcet^®	22,555	21,262	987	948	5,984^b	5,511	15,584	14,803
Codeine	6,825	6,407	380	365	1,869	1,790	4,575	4,252
Demerol^®	2,406^a	1,851	54	42	436^b	294	1,916	1,515
Dilaudid^®	1,100	1,008	14	9	285	257	801	742
Fioricet^®	375	441	15	21	62	49	297	370
Fiorinal^®	257	224	11	25	16	32	230	167
Hydrocodone	10,262	9,779	491	451	3,135^a	2,884	6,637	6,444
Methadone	2,199	2,104	140	150	828	761	1,231	1,192
Morphine	3,036	2,696	160	188	1,020	963	1,856	1,546
OxyContin^®	6,160	5,917	369	369	2,149	2,079	3,642	3,469
Phenaphen^® with Codeine	599	599	50	52	162	170	387	377
Propoxyphene	190	255	35	17	63	54	92	183
SK-65^®	64^a	25	15	7	29	18	19	*
Stadol^®	94	102	3	3	18^b	2	73	97
Talacen^®	39	57	7	8	18	7	14	42
Talwin^®	278	192	10	10	12	*	255	180
Talwin^® NX	63	55	6	12	22^a	5	35	39
Tramadol	1,722^b	2,165	86^b	144	611	712	1,025	1,309
Ultram^®	1,235	1,155	42	32	285	263	908	860
SELECTED GROUPS OF DRUGS¹
Propoxyphene or Codeine Products²	19,734	18,465	1,144	1,066	3,903^b	3,481	14,687	13,917
Oxycodone Products³	15,596	14,817	638	643	3,945	3,777	11,013	10,397
Hydrocodone Products⁴	24,176	23,226	1,146	1,114	6,511^b	6,037	16,519	16,075
Tramadol Products⁵	2,282	2,614	114^a	159	699	794	1,469	1,660

120405

Table 1.89B – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Percentages, 2010 and 2011
Pain Reliever	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	7.1^a	6.4	4.0	3.6	9.5^b	8.1	7.0	6.5
Percocet^®, Percodan^®, or Tylox^®	5.4^a	5.0	1.7	1.7	9.3	8.9	5.2	4.8
Vicodin^®, Lortab^®, or Lorcet^®	8.9^a	8.3	4.1	3.8	17.6^b	16.1	8.0	7.5
Codeine	2.7	2.5	1.6	1.5	5.5	5.2	2.3	2.1
Demerol^®	0.9^a	0.7	0.2	0.2	1.3^b	0.9	1.0	0.8
Dilaudid^®	0.4	0.4	0.1	0.0	0.8	0.7	0.4	0.4
Fioricet^®	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.2
Fiorinal^®	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1
Hydrocodone	4.0	3.8	2.0	1.8	9.2^a	8.4	3.4	3.2
Methadone	0.9	0.8	0.6	0.6	2.4	2.2	0.6	0.6
Morphine	1.2	1.0	0.7	0.8	3.0	2.8	1.0	0.8
OxyContin^®	2.4	2.3	1.5	1.5	6.3	6.1	1.9	1.7
Phenaphen^® with Codeine	0.2	0.2	0.2	0.2	0.5	0.5	0.2	0.2
Propoxyphene	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.1
SK-65^®	0.0^a	0.0	0.1	0.0	0.1	0.1	0.0	*
Stadol^®	0.0	0.0	0.0	0.0	0.1^b	0.0	0.0	0.0
Talacen^®	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
Talwin^®	0.1	0.1	0.0	0.0	0.0	*	0.1	0.1
Talwin^® NX	0.0	0.0	0.0	0.0	0.1^a	0.0	0.0	0.0
Tramadol	0.7^a	0.8	0.4^b	0.6	1.8	2.1	0.5	0.7
Ultram^®	0.5	0.4	0.2	0.1	0.8	0.8	0.5	0.4
SELECTED GROUPS OF DRUGS¹
Propoxyphene or Codeine Products²	7.8^a	7.2	4.7	4.3	11.5^b	10.1	7.5	7.0
Oxycodone Products³	6.1	5.8	2.6	2.6	11.6	11.0	5.6	5.2
Hydrocodone Products⁴	9.5	9.0	4.7	4.5	19.1^b	17.6	8.5	8.1
Tramadol Products⁵	0.9	1.0	0.5	0.6	2.1	2.3	0.8	0.8

120405

Table 1.90A – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Numbers in Thousands, 2010 and 2011
Tranquilizer	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^® or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
Klonopin^® or Clonazepam	4,752	5,094	193	191	1,405	1,433	3,154	3,470
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	13,693	13,657	542	513	3,608	3,494	9,543	9,650
Valium^® or Diazepam	13,509	12,649	215	210	1,999^a	1,750	11,295	10,690
Atarax^®	189	128	23	10	46	30	120	88
BuSpar^®	537	694	13	25	156	196	368	474
Equanil^®	58	67	8	3	8	4	42	60
Flexeril^®	2,584	2,454	56	59	504	563	2,023	1,832
Librium^®	797^a	499	16	8	59	49	723	442
Limbitrol^®	99	54	9	6	15	10	76	37
Meprobamate	64	79	9	21	26	20	29	37
Miltown^®	59	38	10	7	7	5	42	26
Rohypnol^®	337	290	11	22	60	64	266	204
Serax^®	65	50	9	3	26	19	30	28
Soma^®	3,252	3,062	117	83	922	894	2,212	2,086
Tranxene^®	66	140	*	5	19	23	47	112
Vistaril^®	278	254	18	19	56	51	203	184
SELECTED GROUPS OF DRUGS¹
Benzodiazepines²	20,786	20,409	644	644	4,292^a	3,990	15,850	15,776
Meprobamate Products³	159	168	22	26	34	26	104	116
Muscle Relaxants⁴	4,779	4,623	163^a	115	1,162	1,188	3,455	3,320

120405

Table 1.90B – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Percentages, 2010 and 2011
Tranquilizer	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^® or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
Klonopin^® or Clonazepam	1.9	2.0	0.8	0.8	4.1	4.2	1.6	1.7
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	5.4	5.3	2.2	2.1	10.6	10.2	4.9	4.9
Valium^® or Diazepam	5.3	4.9	0.9	0.8	5.9^b	5.1	5.8	5.4
Atarax^®	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0
BuSpar^®	0.2	0.3	0.1	0.1	0.5	0.6	0.2	0.2
Equanil^®	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Flexeril^®	1.0	1.0	0.2	0.2	1.5	1.6	1.0	0.9
Librium^®	0.3^a	0.2	0.1	0.0	0.2	0.1	0.4^a	0.2
Limbitrol^®	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Meprobamate	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
Miltown^®	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Rohypnol^®	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1
Serax^®	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
Soma^®	1.3	1.2	0.5	0.3	2.7	2.6	1.1	1.1
Tranxene^®	0.0	0.1	*	0.0	0.1	0.1	0.0	0.1
Vistaril^®	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1
SELECTED GROUPS OF DRUGS¹
Benzodiazepines²	8.2	7.9	2.6	2.6	12.6^a	11.6	8.1	8.0
Meprobamate Products³	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Muscle Relaxants⁴	1.9	1.8	0.7^a	0.5	3.4	3.5	1.8	1.7

120405

Table 1.91A – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Numbers in Thousands, 2010 and 2011
Stimulant	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn^®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings*. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. ⁶ Includes Ritalin^®, other products containing methylphenidate, and products containing dexmethylphenidate. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
Methamphetamine, Desoxyn^®, or Methedrine¹	13,060	11,928	157	184	1,361^b	1,150	11,542	10,594
Prescription Diet Pills²	7,366	6,586	126	112	699^a	582	6,541	5,892
Ritalin^® or Methylphenidate	5,444	4,918	251	245	1,833	1,687	3,361	2,986
Cylert^®	106	126	9	8	42	34	56	84
Dexedrine^®	1,830	1,898	14	10	148^a	100	1,668	1,788
Dextroamphetamine	794	734	27	29	191	164	576	541
Didrex^®	95	133	7	5	18	21	69	107
Eskatrol^®	96	40	6	5	26^a	6	63	28
Ionamin^®	236	335	5	3	6	12	225	319
Mazanor^®	26	47	3	3	13	7	10	37
Obedrin-LA^®	*	*	*	7	3	*	*	*
Plegine^®	*	17	4	*	8	4	*	13
Preludin^®	429	301	5	3	26	21	398	276
Sanorex^®	50	79	8	4	5	14	37	60
Tenuate^®	62	156	9	6	4	7	49	143
SELECTED GROUPS OF DRUGS³
Amphetamine, Dextroamphetamine, and Phentermine Products⁴	9,554	8,784	202	200	1,546^b	1,302	7,806	7,283
Mazindol Products⁵	73	114	9	7	17	18	47	88
Methylphenidate or Dexmethylphenidate Products⁶	5,468	4,931	259	252	1,845	1,693	3,364	2,986

120405

Table 1.91B – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Percentages, 2010 and 2011
Stimulant	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn^®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings*. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. ⁶ Includes Ritalin^®, other products containing methylphenidate, and products containing dexmethylphenidate. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
Methamphetamine, Desoxyn^®, or Methedrine¹	5.1^a	4.6	0.6	0.7	4.0^b	3.4	5.9	5.3
Prescription Diet Pills²	2.9	2.6	0.5	0.4	2.1^a	1.7	3.4	3.0
Ritalin^® or Methylphenidate	2.1	1.9	1.0	1.0	5.4	4.9	1.7	1.5
Cylert^®	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
Dexedrine^®	0.7	0.7	0.1	0.0	0.4^a	0.3	0.9	0.9
Dextroamphetamine	0.3	0.3	0.1	0.1	0.6	0.5	0.3	0.3
Didrex^®	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1
Eskatrol^®	0.0	0.0	0.0	0.0	0.1^a	0.0	0.0	0.0
Ionamin^®	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2
Mazanor^®	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Obedrin-LA^®	*	*	*	0.0	0.0	*	*	*
Plegine^®	*	0.0	0.0	*	0.0	0.0	*	0.0
Preludin^®	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.1
Sanorex^®	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tenuate^®	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1
SELECTED GROUPS OF DRUGS³
Amphetamine, Dextroamphetamine, and Phentermine Products⁴	3.8	3.4	0.8	0.8	4.5^b	3.8	4.0	3.7
Mazindol Products⁵	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
Methylphenidate or Dexmethylphenidate Products⁶	2.2	1.9	1.1	1.0	5.4	4.9	1.7	1.5

120405

Table 1.92A – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Numbers in Thousands, 2010 and 2011
Sedative	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
Methaqualone, Sopor^®, or Quaalude^®	5,069	5,217	41^a	17	119	96	4,910	5,104
Barbiturates¹	2,024	2,055	20	22	76^a	41	1,928	1,993
Restoril^® or Temazepam	1,034	811	43	32	137	115	853	664
Amytal^®	231	251	5	7	30	17	196	226
Butisol^®	104	72	17	8	16	20	71	45
Chloral Hydrate	132	122	6	5	10	4	116	113
Dalmane^®	219	340	8	5	19	6	192	329
Halcion^®	570	327	23	14	39	17	508	296
Phenobarbital	861	755	24	17	48	29	789	709
Placidyl^®	407	526	5	2	8	*	394	524
Tuinal^®	517	696	2	2	9	*	506	693
SELECTED GROUPS OF DRUGS²
Temazepam, Flurazepam, or Triazolam³	1,557	1,261	68	48	160	129	1,328	1,085
Any Barbiturates⁴	2,648	2,569	55	46	120	87	2,473	2,435

120405

Table 1.92B – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Percentages, 2010 and 2011
Sedative	Total (2010)	Total (2011)	Aged 12-17 (2010)	Aged 12-17 (2011)	Aged 18-25 (2010)	Aged 18-25 (2011)	Aged 26+ (2010)	Aged 26+ (2011)
Low precision; no estimate reported. NOTE: Some 2010 estimates may differ from previously published estimates due to updates (see Section B.3 in Appendix B of the Results from the 2011 National Survey on Drug Use and Health: National Findings*). ^a Difference between estimate and 2011 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2011 estimate is statistically significant at the 0.01 level. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2010 and 2011.
Methaqualone, Sopor^®, or Quaalude^®	2.0	2.0	0.2^a	0.1	0.3	0.3	2.5	2.6
Barbiturates¹	0.8	0.8	0.1	0.1	0.2^a	0.1	1.0	1.0
Restoril^® or Temazepam	0.4	0.3	0.2	0.1	0.4	0.3	0.4	0.3
Amytal^®	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1
Butisol^®	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
Chloral Hydrate	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1
Dalmane^®	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2
Halcion^®	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1
Phenobarbital	0.3	0.3	0.1	0.1	0.1	0.1	0.4	0.4
Placidyl^®	0.2	0.2	0.0	0.0	0.0	*	0.2	0.3
Tuinal^®	0.2	0.3	0.0	0.0	0.0	*	0.3	0.3
SELECTED GROUPS OF DRUGS²
Temazepam, Flurazepam, or Triazolam³	0.6	0.5	0.3	0.2	0.5	0.4	0.7	0.5
Any Barbiturates⁴	1.0	1.0	0.2	0.2	0.4	0.3	1.3	1.2